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Malaria is a disease that kills several hundred thousands annually. The disease 
is caused by protozoan parasites of the Plasmodium genus. Of the species that 
infect humans, P. falciparum is responsible for the vast majority of deaths. 
The parasite has a complex life cycle that involves a mosquito stage, a liver 
stage, and an erythrocytic asexual stage. It is during the erythrocytic cycle that 
the clinical manifestations of infection occur. Here, the parasite grows within a 
host erythrocyte, progressing through the ring, trophozoite, schizont and 
merozoite forms. In the trophozoite and schizont forms, a distinctive organelle 
known as the digestive vacuole is present. This organelle facilitates the 
digestion of hemoglobin from the host red blood cell, providing the parasite 
with nutrients and space to grow within the cell. Dosing the parasite with high 
concentrations of an old antimalarial drug, chloroquine, was discovered a few 
years ago to result in the lysis of this organelle. Downstream of this, DNA 
degradation and mitochondrial depolarization occurred, reminiscent of 
mammalian apoptosis. 
 
This thesis explores the effects of digestive vacuole permeabilization. First, a 
high-content screen using an imaging flow cytometer was developed. This 
enabled the identification of a further two compounds that could disrupt the 
digestive vacuole in a chloroquine-sensitive strain, 3D7. These compounds 
were able to similarly induce the apoptosis-like features that chloroquine 
treatment achieved, bolstering the hypothesis that digestive vacuole rupture 
can result in a specific form of cell death similar to apoptosis. Further 
investigations with 3D7 showed that the rupture of the digestive vacuole did 
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indeed correlate with parasite death, as well as the manifestation of the 
apoptosis-like phenotypes. However, in a chloroquine-resistant strain, K1, the 
depolarization of the parasite mitochondrion by chloroquine treatment was 
unable to effectively kill the parasite, belying the proposal that mitochondrial 
depolarization is a cell death feature in the parasite. Furthermore, apoptotic 
mammalian cells are efficiently cleared by phagocytes through externalization 
of phosphatidylserine. Here, parasites with ruptured digestive vacuoles do not 
present higher levels of phosphatidylserine, and are not more efficiently 
phagocytosed by the monocyte model THP-1. 
 
On the other hand, the parasite resides within a host red blood cell. Human 
erythrocytes have a mode of programmed cell death unlike apoptosis. In 
senescent erythrocytes, influx of Ca2+ activates the cysteine protease μ-
calpain, resulting in cytoskeletal degradation. Parasite invasion of the 
erythrocyte causes the erythrocyte membrane to be permeable to Ca2+. 
However, Ca2+ activity in the erythrocyte cytosol is suppressed as the parasite 
sequesters Ca2+ in various organelles, one of which is the digestive vacuole. P. 
falciparum also expresses knobs on the erythrocyte surface in order to adhere 
to the endothelial lining and remove itself from the peripheral circulation. This 
enables the parasite to avoid phagocytic clearance by the spleen. Formation of 
these knobs require the parasite protein KAHRP and its attachment to the host 
cytoskeleton. It was discovered that rupture of the digestive vacuole appears to 
induce the μ-calpain death pathway of the erythrocyte, resulting in the 
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1.1 Malaria: from past to present 
Malaria is an ancient disease. The fossil record shows that malarial parasites 
existed 100 million years ago, and the genus Plasmodium, responsible for 
human malaria among other vertebrates, was already established in the New 
World 15 million years ago (Poinar, 2016). Malaria has been with us since 
before we were humans, and has greatly affected our evolutionary journey 
(Carter and Mendis, 2002; Kwiatkowski, 2005). The most virulent human 
species, P. falciparum, is thought to be a relatively recent pathogen that 
switched to humans from gorillas (Liu et al., 2010). In ancient texts, malaria 
was often recorded as marsh fever, ague, intermittent fever, tertian fever, or 
quartan fever (Hempelmann and Krafts, 2013). In fact, the name malaria 
derives from the Italian “mal’aria”, or bad air, arising from the observation 
that malaria was associated with marshes and swamps (Meshnick and Dobson, 
2001). Malaria’s influence on the lives of humans is demonstrated in the 
origin of the word abracadabra as a charm to ward against the disease 
(Hempelmann and Krafts, 2013). Even King Tutankhamun was not spared 
from the ravages of this disease (Hawass et al., 2010). It was only at the end of 
the nineteenth century that the cause of malaria was attributed to a parasite and 
its mosquito vector, from the works of Alphonse Laveran, Ronald Ross, and 
Giovanni Battista Grassi amongst others (Cox, 2010; Guillemin, 2002). 
 
Given the mosquito-borne nature of this disease, it is logical to speculate that 
malaria prevalence would be higher in regions that are more conducive of the 
mosquito vector, i.e., warmer, wetter regions. This is borne out by data 
showing that falciparum malaria is mostly limited to the tropical and sub-
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tropical regions of the world (Gething et al., 2011). This posed a major 
problem to the European powers during the pre-20th century, halting their 
expansion into the tropical regions and making malaria one of the best-studied 
diseases in Western medicine at the time. In fact, the first purified 
antimicrobial compound used was the antimalarial drug quinine (QN) in the 
19th century. Similarly, the first synthetic drug ever used in humans was the 
dye methylene blue, by the German scientist Paul Erhlich who successfully 
treated two patients with it (Achan et al., 2011; Meshnick and Dobson, 2001). 
Malaria also played an important role in both World Wars. In the first World 
War, at which time the primary treatment and prophylaxis was QN, malaria 
infected at least 1.5 million soldiers and killed up to 75 000 (Brabin, 2014). 
During the Second World War, quinacrine (QC), developed from the afore-
mentioned methylene blue, was used as a treatment and prophylaxis against 
falciparum malaria in the Pacific theatre. Japanese propaganda, through radio 
broadcasts of a woman by the name of Tokyo Rose, convinced many soldiers 
that QC causes skin and eye discolouration (which was true) and sterility 
(which was not). Their refusal to adhere to the QC regimen resulted in a 
concerted effort by US scientists to develop a new antimalarial drug (Butler et 
al., 2010). This resulted in the rediscovery of one of the most impactful 
antimalarial drug ever, chloroquine (CQ), which was originally discovered by 
the German chemist Johann Andersag but was erroneously believed to be too 
toxic for clinical use, an incident which became known as “the resochin error” 
(resochin being the name Andersag gave the compound) (Coatney, 1963; 
Krafts et al., 2012). CQ was so potent in the treatment of malaria that it 
inspired optimism for the eradication of this disease. However, resistance 
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evolved shortly after, first arising along the Thai-Cambodian border in the 
1950s. By the 1970s, CQ resistance had propagated throughout the world 
(Butler et al., 2010; Wellems and Plowe, 2001), rendering it ineffective as a 
first-line chemotherapy against P. falciparum. The rather indiscriminate 
addition of CQ to household salt has been blamed for this development 
(Payne, 1988), and it has stimulated debate on strategies to slow the 
emergence of resistance such as through combination therapies (Bloland et al., 
2000; Nosten and Brasseur, 2002). Once again, a military conflict led to new 
drugs against the malaria parasites. In the Vietnam War, CQ-resistant P. 
falciparum was a major problem for both sides. The US developed mefloquine 
(MQ), a drug targeting the hemoglobin digestion pathway of the parasite. The 
People’s Republic of China, supporting the North Vietnamese in the conflict, 
began a secret military project termed Project 523 (for May 23) in 1967. A 
part of Project 523 involved the surveying of traditional Chinese anti-malarial 
medicines; from these, the extract of a wormwood, Artemisia annua L. 
(Qinghao in Mandarin) proved very potent against the malaria parasite. 
Further purification of this extract led to the discovery of artemisinin, our 
current front-line drug against P. falciparum (Miller and Su, 2011; Tu, 2011). 
 
In addition to its dependence on mosquitoes for transmission, human activity 
and climate change can bring malaria beyond these tropical locales: in 1922, a 
malaria epidemic broke out just south of the Arctic Circle in the Russian port 
city of Archangel due to a confluence of climatic and economic events, 
resulting in a thousand deaths (Packard, 2007). There is therefore no guarantee 
that, in these times of rapid climate change, malaria will be limited to its 
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current endemicity. Malaria is also a disease that runs along socioeconomic 
lines. Poorer geographical regions are at higher risk of morbidity and 
mortality, which in turn suppresses the economic growth of the region and 
thus resulting in a vicious cycle (Sachs and Malaney, 2002). It is therefore not 
surprising that the majority of malaria-attributable deaths occur in the poorest 
nations, with African countries accounting for 88% of the 214 million cases 
and 90% of the 438 000 deaths worldwide in 2015; of these deaths, 
approximately 70% accrue to children under the age of 5. Although 
horrendously large, these numbers are a far cry from the situation in 2000. 
Compared to the year 2000, 2015 saw a decrease of 48% in the number of 
malaria deaths, and averted a cumulative 6.8 million deaths throughout this 
period (World Health Organization, 2015).  
 
1.1.1 Malaria today 
This success is largely attributed to indoor residual spraying of insecticides 
and insecticide-treated bed nets to prevent transmission by mosquitoes, 
followed by artemisinin-based combination therapy when prevention fails; the 
requirement of a mosquito vector for malaria transmission has instigated anti-
malarial strategies targeting the mosquito. However, various shortcomings 
have manifested in these measures, such as resistance to the insecticides 
(Mabaso et al., 2004; N’Guessan et al., 2007; Trape et al., 2011). In West 
Africa, use of bed nets to prevent night feeding by the nocturnal Anopheles 
mosquitoes resulted in a behavioural switch by A. fenestus to crepuscular 
feeding instead (Moiroux et al., 2012), frustrating efforts to limit this disease. 
Furthermore, as continuous exposure to the parasite is required for the 
6 
 
maintenance of protective immunity, these interventions may result in rebound 
malaria or shift the incidence of malaria to a later age (Trape et al., 2011). 
Later onset is potentially more dangerous as it is associated with an increased 
severity of certain manifestations of malaria, such as cerebral malaria (Doolan 
et al., 2009). Attempts to engineer vaccines have mostly floundered, but a 
promising candidate has recently completed clinical trials; the vaccine reduced 
a substantial number of malaria cases in children but this protection was not 
long-lived (Gosling and Seidlein, 2016; RTS,S Clinical Trials Partnership, 
2015). The World Health Organization (2015) recommends artemisinin-
combination therapy for malaria treatment, but worryingly, artemisinin 
resistance is spreading (Ashley et al., 2014). In light of this, there is an urgent 
need to develop new strategies against malaria before the hard-won gains 
against this life-threatening disease are completely eroded. 
 
1.1.2 Rationale 
Programmed cell death (PCD) in P. falciparum was first proposed in 1997, 
when DNA fragmentation was observed after CQ treatment (Picot et al., 
1997). Since then, multiple groups have reported a variety of PCD-like 
features similar to those present in mammalian cells. In our laboratory, we 
found that these apoptosis-like features manifested after permeabilization of 
the digestive vacuole (DV) and are mediated by cysteine proteases (Ch’ng et 
al., 2011). Development of an assay for high-content screening of DV-
disruptive compounds will enable us to identify leads that take advantage of 
this novel mode of cell death. In addition, given the high concentrations of CQ 
previously used to induce DV permeabilization, we sought to characterize the 
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minimum dose and duration required for this phenomenon. Although CQ 
resistance is widespread, work on chemosensitizing agents may one day allow 
CQ to be reintroduced as a chemotherapy for P. falciparum malaria. As the 
parasite resides in a host erythrocyte for the vast majority of the erythrocytic 
cycle, induction of DV permeabilization in the parasite may also impact the 
host erythrocyte. Beyond that, this PCD-like death may also influence the 
interaction of the parasite with the host; therefore, presented in this thesis are 
also the effects of DV disruption on parasite engulfment by phagocytes as well 




2. Literature review  
9 
 
2.1 Biology of P. falciparum 
2.1.1 Life cycle of the parasite 
The most virulent malarial parasite, P. falciparum, accounts for the vast 
majority of malaria deaths. Apart from P. falciparum, the three other major 
species to infect humans are P. vivax, P. ovale, and P. malariae. More 
recently, two parasites of macaques, P. knowlesi and P. cynomolgi, were found 
to naturally infect humans (Ta et al., 2014; White, 2008), with P. knowlesi 
being implicated in a large proportion of malaria in Malaysian Borneo (Cox-
Singh et al., 2008). Plasmodium has a complex life cycle involving two host 
species, a vertebrate host and an insect host. All species of human-infecting 
Plasmodium are transmitted by female Anopheles mosquitoes. The infection is 
initiated in humans when a carrier mosquito takes a blood meal and injects 
worm-like sporozoites from the mosquito’s salivary glands into the dermis. In 
mouse models, the sporozoites may travel to the liver via the 
cardiovasculatory system, be transported to a proximal lymph node via the 
lymphatic system where they are degraded by dendritic cells, or remain in the 
dermis until motility is exhausted (Amino et al., 2006). P. berghei sporozoites 
that remain in the skin of the mice may, surprisingly, develop into erythrocyte-
infective forms (Gueirard et al., 2010). In P. falciparum, however, 
development in the skin has yet to be shown, and transport to the liver is vital 
for the infection to progress. At the liver, the sporozoite transverses several 
host cell types prior to arriving at the hepatocyte target, and knockout of 
transversal renders the sporozoite susceptible to clearance by phagocytes 
(Amino et al., 2008). In the hepatocyte, P. falciparum progresses through 
exoerythrocytic schizogony with drastic changes in morphology, culminating 
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in the budding out of merosomes and subsequent release of tens of thousands 
of lemon-shaped merozoites into the blood (Vaughan et al., 2012). The 
merozoites then invade erythrocytes, initiating the erythrocytic stage of the 
Plasmodium life cycle. Inside the red cell, the parasite progresses from the 
signet-ring form to the trophozoite, then to the schizont form, generating 
merozoites which reinvade erythrocytes and perpetuate the infection, the 
egress of the parasites from the erythrocytes manifesting as the periodical 
fevers so characteristic of malaria. Some of these blood-stage parasites 
develop into male and female transmission stages known as gametocytes, 
which are then taken up by mosquitoes during a blood meal. Sexual 
reproduction occurs in the mosquito midgut, producing sporozoites that 
migrate to the salivary glands of the mosquito, ready to be inoculated into the 
next unfortunate host.  
 
2.1.2 Erythrocytic stage  
As the erythrocytic stage of P. falciparum is the focus of this dissertation, a 
more detailed overview of this stage of the parasite is presented here. The 
merozoite is approximately 1.6 μm long and is ovoid-shaped. One end of the 
merozoite slightly protrudes and is termed the apical prominence; this end of 
the merozoite also houses the rhoptries and micronemes (Bannister et al., 
2000; Cowman and Crabb, 2006). Upon contact with an erythrocyte, the 
merozoite may attach at any point of its surface but rapidly reorients to 
position the apical end towards the erythrocyte; this event is strong enough to 
“wave” the erythrocyte about if the merozoite is immobilized (Gilson and 
Crabb, 2009). A tight junction is then formed with the erythrocyte at the apical 
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end of the merozoite, which gradually moves towards the posterior end of the 
merozoite as the merozoite “pushes” itself into the erythrocyte. This 
invagination of the erythrocyte membrane forms the parasitophorous vacuole 
as the merozoite enters the cell. This entire process takes only approximately 
28 seconds, after which the host erythrocyte undergoes a short echidnocytosis 
phase before it recovers its typical morphology (Gilson and Crabb, 2009). The 
parasite thus enters its ring form in the erythocyte. The ring form is named for 
its appearance in a Giemsa smear, but its actual morphology is disc- or cup-
shaped, and sometimes exhibits branching (Bannister et al., 2004). Early on, 
the parasite is transcriptionally quiescent, but as the parasite grows the total 
amount of RNA increases quickly (Martin et al., 2005). The ring form of the 
parasite does internalize hemoglobin through cytostomes (Bakar et al., 2010; 
Elliott et al., 2008; Lazarus et al., 2008), and some degradation of hemoglobin 
occurs (Xie et al., 2016). Other organelles common to eukaryotes such as the 
mitochondrion, endoplasmic reticulum, and Golgi complex are also present, 
and enlarge as the parasite grows. The apicoplast, a characteristic organelle 
present in most organisms of the phylum Apicomplexa, is also present in P. 
falciparum. The ring form of the parasite lasts approximately 24 h, through 
which it gradually transforms into the trophozoite form and increases in 
sphericity. The first appearance of the malarial pigment, hemozoin, under light 
microscopy signifies the start of the trophozoite form. In this phase, the rate of 
hemoglobin degradation accelerates. The hemozoin is situated within an 
organelle known as the digestive vacuole (DV) or food vacuole. How the DV 
forms is still contentious. One hypothesis, based on observations of electron 
micrographs of ring form parasites, puts forth that a “Big Gulp” event occurs 
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when the disc-like parasite invaginates to form a cup which then seals off, thus 
creating a large hemoglobin-filled compartment in the parasite that becomes 
the DV (Elliott et al., 2008). Others have proposed that the cytostome-
mediated endocytic vesicles in the ring form fuse to generate the DV, shown 
by tracing hemoglobin ingestion with a fluorescent probe (Bakar et al., 2010). 
Regardless of how it is formed, the DV is crucial for growth of the parasite. 
Here, the host erythrocyte’s hemoglobin is degraded by enzymatic digestion in 
an acidic environment of about pH 5.5 (Goldberg et al., 1990; Klonis et al., 
2007). Surprisingly, experiments with radiolabelled amino acids showed that 
the parasite only uses a small fraction of the amino acids derived from this 
digestion (Krugliak et al., 2002), suggesting another role for hemoglobin 
degradation. In fact, mathematical models and some experimental data support 
the idea that hemoglobin degradation is essential for the osmotic stability of 
infected erythrocytes and to make space for parasite growth (Lew et al., 2003, 
2004). The DV also plays another important role, which is to sequester the 
degradation by-product, heme, in the form of hemozoin. Free heme at high 
concentrations is cytotoxic, as it can disrupt membrane bilayers, generate 
reactive oxygen species, and inhibit protein activity (Sigala and Goldberg, 
2014). Biocrystallization of heme to the more benign hemozoin thus protects 
the parasite. The conversion of hemoglobin to hemozoin is catalyzed by a 
protein complex comprising falcipain 2, plasmepsins, and heme detoxification 
protein, among others (Chugh et al., 2013). The host erythrocyte is extensively 
remodelled at this stage by the export of parasite proteins, possibly mediated 
by Maurer’s clefts (Bhattacharjee et al., 2008). The erythrocyte plasma 
membrane becomes increasingly permeable as new permeability pathways are 
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formed to allow for increased uptake of nutrients and to dispose of metabolic 
waste (Baumeister et al., 2006; Ginsburg et al., 1983; Kutner et al., 1985). The 
host plasma membrane also rigidifies and, on most clinical isolates, knobs 
appear and increase in density (Glenister et al., 2002; Maier et al., 2008; Quadt 
et al., 2012). The parasite progresses to the next phase, the schizont form. 
Here, the parasite undergoes rapid rounds of asynchronous DNA replication, 
forming up to 32 nuclei which are distributed to merozoites (Reilly et al., 
2007). Most of the hemoglobin have been digested, and the DV takes up a 
large volume of the cell. The single mitochondrion and apicoplast grow into 
large branched structures, then fragment and are jointly segregated into the 
merozoites (van Dooren et al., 2005). The parasitophorous vacuole and red 
blood cell membrane then rupture, releasing the DV and the merozoites. 
 
2.2 Pathogenesis of malaria 
2.2.1 Fever  
In non-immune individuals, P. falciparum infection manifests clinically as 
malaria. The erythrocytic stage of P. falciparum develops over a 48 h cycle; 
this corresponds with the characteristic tertian fever seen in both P. falciparum 
and P. vivax malaria. This fever is believed to be triggered at the end of each 
erythrocytic cycle when the schizonts rupture and release their intracellular 
contents, activating splenic macrophages and monocytes and inducing 
systemic inflammation with elevated levels of circulating cytokines 
(Gazzinelli et al., 2014). In particular, the release of hemozoin at the end of the 
cycle appears to play an important role. Synthetic hemozoin activates the 
NACHT, LRR and PYD domains-containing protein 3 (Nalp3) inflammasome 
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in myeloid-lineage cells, causing the release of the proinflammatory cytokine 
interleukin-1β (Dostert et al., 2009; Shio et al., 2009). Interestingly, hemozoin 
can also activate Toll-like receptor 9, but only if it is bound to Plasmodium 
DNA (Parroche et al., 2007). Hemozoin also interferes with the microbicidal 




Anaemia is another common syndrome in malaria. The aforementioned 
rupture of infected red blood cells (iRBCs) contribute to this directly, and 
together with the wide range of erythroid cells P. falciparum can infect 
compared to other malaria species, may explain why P. falciparum is so 
deadly. Ring-infected as well as uninfected RBCs (uRBCs) are also less 
deformable, and are cleared by the spleen as they circulate (Buffet et al., 
2011). Pitting may also occur in the spleen, a process that removes the parasite 
from the RBC and returns the once-infected RBC back into circulation (Angus 
et al., 1997). Although this may mitigate anaemia caused by destruction of the 
erythrocytes during parasite egress, these RBCs are short-lived and will soon 
be removed from circulation (Newton et al., 2001). Interestingly, as evidenced 
by mathematical modelling or rodent models, the vast majority of erythrocytes 
destroyed during malaria are non-infected (Evans et al., 2006; Jakeman et al., 
1999). Other non-splenic routes of uRBC destruction could be the deposition 
of the merozoite protein RSP2 from aborted invasion attempts followed by 
phagocytosis or complement activation (Douki et al., 2003; Fernandez-Arias 
et al., 2016; Layez et al., 2005; Odhiambo et al., 2008). Anaemia is also 
15 
 
exacerbated by dysfunction in erythropoiesis (Lamikanra et al., 2009, 2015; 
Pathak and Ghosh, 2016). In severe malaria, severe anaemia may result in 
haematocrit levels below 15%; in healthy adults hematocrit levels range from 
40% to 54% for men and 36% to 48% for women (Billett, 1990; World Health 
Organization, 2012). 
 
2.2.3 Cerebral malaria 
Cerebral malaria is another manifestation of severe malaria in which patients 
progress to a comatose state. Cerebral malaria is associated with blockage of 
the cerebral microvasculature (MacPherson et al., 1985). Late forms of the 
erythrocytic stage parasites express knobs on the erythrocyte membrane that 
mediate parasite adhesion to the endothelial surface of the vessels, 
sequestering the trophozoite and schizont forms from systemic circulation. 
Many receptors for parasite adhesion have been reported, but the most well-
studied are CD36 and ICAM-1 (Rowe et al., 2009). Interestingly, although 
CD36 is ubiquitously expressed on most endothelial cells it is only weakly 
expressed in the cerebral endothelium, while ICAM-1 expression during 
malaria is significantly upregulated in the brain (Turner et al., 1994, 1998). 
Even without direct cytoadhesion to the endothelium, the parasite may cause 
cerebral malaria by other means. IRBCs can bind to neighbouring uRBCs, 
forming large rosettes (Carlson et al., 1990; Cockburn et al., 2004). As 
platelets express CD36, they may also act as a bridge to CD36-binding iRBCs, 
while the platelets themselves attach to the cerebral endothelium (Wassmer et 
al., 2004). The increased rigidity of infected and uninfected bystander 
erythrocytes may also contribute to abnormal blood flow in the brain 
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(Dondorp et al., 2000). Other contributory factors to cerebral malaria include 
production of pro-inflammatory cytokines, apoptosis of the endothelial cells, 
and transfer of parasite material to the endothelial lining through a process 
known as trogocytosis, disrupting the blood-brain barrier (Hunt and Grau, 
2003; Jambou et al., 2010; Touré et al., 2008). 
 
2.2.4 Metabolic acidosis 
Respiratory distress is an important prognostic marker for mortality in African 
children suffering from malaria (Marsh et al., 1995). The underlying aetiology 
is most often metabolic acidosis (English et al., 1996). This is generally 
attributed to anaemia and occlusion of blood vessels as described above, 
leading to the increased production of lactate; this is further complicated by 
impaired renal and hepatic function (Day et al., 2000). Hypovolemia due to a 
septic shock-like response has also been proposed as a contributor to 
metabolic acidosis (Maitland and Newton, 2005). 
 
2.2.5 Pregnancy-associated malaria 
Even in previously-immune individuals, the first pregnancy (primigravidity) 
exposes the woman to more severe disease and the fetus to developmental 
complications (McGregor, 1984). Why this is so is unclear; however, there is 
evidence that immunomodulation in pregnancy plays a strong role (Rogerson 
et al., 2007). In these patients, parasites are frequently found sequestered in the 
placenta (Beeson et al., 2002). Unlike parasites isolated from other patients, 
pregnancy-associated parasites do not bind to CD36 but utilize chondroitin 
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2.3 Chemotherapy and resistance 
2.3.1 Inhibition of heme biocrystallization 
During development within the erythrocyte, hemoglobin is ingested and 
degraded in the DV of the parasite. The digestion of hemoglobin produces free 
heme, which is toxic to the parasite and is biocrystallized into the benign 
hemozoin pigment (Hempelmann, 2007). Quinoline antimalarials include CQ, 
MQ, QN, amodiaquine and piperaquine. CQ and amodiaquine are 4-
aminoquinolines, MQ and QN are quinoline methanols, and piperaquine is a 
bis-4-aminoquinoline that is structurally similar to CQ. Broadly, quinolines 
are thought to inhibit the formation of hemozoin, resulting in an accumulation 
of cytotoxic heme (Foley and Tilley, 1998; Mungthin et al., 1998). 
Lumefantrine is an arylamino-alcohol compound that, based on structural 
similarities to CQ, is believed to also function in a similar manner (Nosten et 
al., 2012). As the bulk of hemoglobin degradation occurs in the later stages of 
the erythrocytic cycle, these drugs are most effective against these stages. 
 
Of the quinoline drugs, CQ is by far the best-studied. The quinoline 
component of CQ is a weak base and is thus uncharged at cytosolic pH. In the 
acidic environment of the DV, it is protonated and CQ becomes membrane-
impermeable, thus accumulating in the DV through ion trapping. It binds to 
the growing surface of hemozoin or to free heme dimers in solution and 
inhibits further growth of the crystal (Gildenhuys et al., 2013; Leed et al., 
2002; Olafson et al., 2015; Walczak et al., 2011). This is the best-evidenced 
mechanism by which CQ kills the parasite. Multiple other modes of action 
have been proposed for CQ to varying controversy, such as intercalation with 
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DNA (Meshnick, 1990; O’Brien et al., 1966), inhibition of hemoglobinases 
(Chugh et al., 2013), and from our laboratory, permeabilization of the DV 
leading to PCD-like phenotypes (Ch’ng et al., 2011). Similarly, both MQ and 
QN have been proposed to kill the parasite by alternative pathways than 
inhibition of heme polymerization, due to the fact that they are weaker bases 
than CQ and may not be as potent an inhibitor of heme polymerization (Saifi, 
2013). 
 
Resistance against CQ propagated slowly. It took almost 40 years for CQ 
resistance to become widespread (Slater, 1993). Because of CQ’s massive 
success before resistance arose, CQ resistance is probably the best-studied 
resistance mechanism in P. falciparum. In the acidic DV, CQ is diprotonated 
and accumulates in this organelle as it is no longer able to diffuse across the 
DV membrane. The P. falciparum CQ resistance transporter, PfCRT, is a 
membrane-bound transporter protein localized on the DV membrane. In 
susceptible strains, the 76th residue of this protein is a lysine, which, at the pH 
of the DV, carries a positive charge and thus electrostatically hinders the 
transport of diprotonated CQ out of the DV. Resistant isolates almost 
invariably have this residue substituted with the uncharged amino acid 
threonine, allowing the efflux of CQ from its site of action (Lakshmanan et al., 
2005; Summers et al., 2014). Inhibition of this efflux is possible as 
exemplified by the canonical PfCRT efflux inhibitor verapamil (Martin et al., 
1987; Martiney et al., 1995), but this compound has poor oral bioavailability. 
Development of novel efflux inhibitors is an active area of research 
(Bhattacharjee et al., 2002; Henry et al., 2006; Oduola et al., 1998; Peyton, 
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2012; van Schalkwyk et al., 2001). Apart from PfCRT, mutations in the 
multidrug resistance protein (PfMDR1; also known as P-glycoprotein 
homologue 1, Pgh-1) encoded by the pfmdr1 gene has sometimes been 
implicated in CQ resistance, perhaps as a rare alternate mechanism of 
resistance or as a compensatory mutation (Andriantsoanirina et al., 2010; 
Foote et al., 1990; Reed et al., 2000). On the other hand, pfmdr1 amplification 
increases susceptibility of the parasite to CQ, possibly by assisting in the 
influx of CQ into the DV as PfMDR1 is predicted to transport substrates 
directionally into the DV (Barnes et al., 1992; Es et al., 1994; Sanchez et al., 
2008); this is further bolstered by the finding that diprotonation of the weakly 
basic CQ is insufficient to fully account for its accumulation in the DV, and 
that CQ accumulation is ATP-dependent (Krogstad et al., 1992). Wild-type 
PfMDR1 has also been shown to bind a CQ analogue (Pleeter et al., 2010). 
Taken together, mutant PfMDR1 may contribute to CQ resistance in some 
genetic backgrounds, but wild-type forms of the protein assist in sensitizing 
the parasite to CQ by transporting CQ into the DV. Interestingly, pfmdr1 
amplification is incompatible with PfMDR1-mediated CQ resistance (Barnes 
et al., 1992). 
 
Resistance against the other inhibitors of heme polymerization has also been 
reported but the mechanisms by which resistance is acquired are less clear 
than those for CQ. PfCRT mutations have been implicated in resistance 
against amodiaquine and QN to some extent (Beshir et al., 2010; Cooper et al., 
2002; Ochong’ et al., 2003; Sidhu et al., 2002). Amplification of pfmdr1 can 
confer resistance against MQ, QN and lumefantrine (Price et al., 2006; Reed et 
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al., 2000), and single nucleotide polymorphisms are linked to differential 
parasite responses to MQ and lumefantrine (Anderson et al., 2005). A sodium-
proton exchanger, pfnhe-1, is associated with QN resistance in certain regions 
of the world (Ménard et al., 2013). Resistance against piperaquine (in 
combination with dihydroartemisinin) was recently reported, and may also 
involve a pfcrt mutation and pfmdr1 deamplification (Amaratunga et al., 2016; 
Eastman et al., 2011). 
 
2.3.2 Artemisinins 
Artemisinins are sesquiterpene lactones containing an essential endoperoxide 
bridge. The mechanism of action for this class of antimalarial drugs is 
currently controversial, but requires hemoglobin degradation to activate the 
compound (Klonis et al., 2011). Reports include heme binding, protein 
alkylation, inactivation of the SERCA-like PfATP6, oxidative membrane 
damage, disruption of the electron transport chain, and promiscuous direct 
binding to a large number of intracellular targets (Bray et al., 2005; O’Neill et 
al., 2010; Wang et al., 2015). Artemisinin-based combination therapies are our 
current first-line treatment for uncomplicated P. falciparum malaria. 
 
Resistance against the artemisinin drugs was first reported at the Thailand-
Cambodia and the Thailand-Myanmar borders (Dondorp et al., 2010; Phyo et 
al., 2012). Worryingly, resistance appears to be spreading (Ashley et al., 
2014). Artemisinin monotherapy results in high recrudescence rates (Hassan 
Alin et al., 1996). This observation led to the suggestion that artemisinin 
treatment could induce parasitic dormancy (Codd et al., 2011; Teuscher et al., 
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2010). Supporting this, laboratory-evolved resistant strains exhibited 
developmental arrest when exposed to artemisinin, but was able to resume 
growth upon drug withdrawal (Witkowski et al., 2010). Clinical isolates from 
patients with delayed parasite clearance were also able to tolerate brief 
durations of artemisinin treatment early in intraerythrocytic development 
(Witkowski et al., 2013a). Given the short half-lives (1-3 hours) of 
artemisinins in the body (Ashton et al., 1998; Gordi et al., 2002), quiescence is 
a reasonable hypothesis for artemisinin resistance. A novel test for artemisinin 
resistance uses very young ring-stage parasites to assess susceptibility 
(Witkowski et al., 2013b); it may be that the parasites lie dormant at this stage 
and avoid generating the heme that is required for artemisinin activation. 
 
Recent genome sequencing of a resistant laboratory strain and slow-clearing 
clinical isolates from Cambodia revealed a strong correlation between several 
kelch13 alleles and parasite clearance half-lives (Ariey et al., 2014). This 
protein is predicted to be involved in either ubiquitin-mediated protein 
degradation or oxidative stress response, but further characterization of this 
protein and its contribution to artemisinin resistance is required. However, 
there is good evidence from genetic manipulations that kelch13 mutations 
indeed mediate artemisinin resistance, through conferring resistance by 
transplanting mutant versions of the gene or generating revertants (Straimer et 
al., 2015). In vitro experiments have also suggested that kelch13 mutants are 
less able to polyubiquitinate phosphatidylinositol-3-kinase, thus achieving 
higher levels of this enzyme and its product phosphatidylinositol-3-phosphate; 
this appears to impart protection against artemisinin (Mbengue et al., 2015). 
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How this can be reconciled with the various reported modes of action of 
artemisinin is still to be clarified. Intriguingly, PfMDR1 is once again linked 
to resistance, through analyses of polymorphisms or copy number variations 
(Cui et al., 2012; Lim et al., 2009; Veiga et al., 2011), although others have 
reported a lack of evidence for the involvement of PfMDR1 (Pirahmadi et al., 
2013; Pradines et al., 2011). Another candidate for artemisinin resistance is the 
sarco/endoplasmic reticulum calcium-dependent ATPase, PfATP6, which was 
previously reported as a target of artemisinin (Eckstein-Ludwig et al., 2003; 
Jambou et al., 2005; Pillai et al., 2012). 
 
2.3.3 Other antimalarials 
The most successful antimalarial drugs appear to avoid parasite-coded targets. 
This is contrasted with another major class of antimalarial drugs, the 
antifolates, which inhibit either the parasite dihydrofolate reductase or the 
dihydropteroate synthase, both of which are required for de novo folate 
biosynthesis in the parasite. As P. falciparum is unable to acquire dTMP from 
the exogenous medium, this pathway is essential to the parasite (Nzila, 2012). 
Antifolates are particularly susceptible to parasite resistance through mutations 
in these drug targets (Gregson and Plowe, 2005), possibly due to the haploid 
state of the erythrocytic stage parasites. Resistance against sulfadoxine-
pyrimethamine, a synergistic combination of inhibitors against 
dihydropteroate synthase and dihydrofolate reductase respectively, arose 
within 5 years of introduction; a single nucleotide polymorphism in the dhfr 
gene can confer a 100-fold resistance to pyrimethamine (Sibley et al., 2001). 
Atovaquone is an inhibitor of the cytochrome bc1 complex on the inner 
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mitochondrial membrane, thus disrupting the electron transport chain (Fry and 
Pudney, 1992). Used as a monotherapy, resistant parasites emerge quickly; it 
is therefore paired with proguanil, another dihydrofolate reductase inhibitor. 
Unfortunately, resistance against this combination of drugs has also evolved, 
and can be explained by polymorphisms of the cytochrome b gene (Gil et al., 
2003). 
 
2.4 Programmed cell death 
Few, if any, cell biologists are unfamiliar with PCD. PCD is defined as any 
mode of cell deletion mediated by innate intracellular processes (Ouyang et 
al., 2012), as opposed to cell death by mechanical injury or other external 
insults. It must be noted here, however, that the various types of PCD lie on a 
continuum with non-programmed forms of death, and should not be viewed as 
a categorically distinct state (Formigli et al., 2000; Zeiss, 2003). The first 
description of a PCD pathway, apoptosis, in 1972 proposed that cells initiate a 
non-inflammatory death pathway in order to limit population density (Kerr et 
al., 1972; Vaux, 2002). Since then, several other mechanisms have been added 
to the repertoire of cell suicide, such as autophagy-mediated cell death 
(Tsujimoto and Shimizu, 2005), programmed necrosis (Han et al., 2011) and 
pyroptosis (Bergsbaken et al., 2009). The reasons for cell suicide are manifold; 
some examples are sculpting of embryonic structures (Fuchs and Steller, 
2011), deletion of possibly harmful T and B cells (Cohen et al., 1992), killing 
of infected cells (Roulston et al., 1999), and regulation of erythrocyte turnover 
(Lang et al., 2012). It is readily apparent that PCD in metazoans can reap great 
benefits – as multicellular organisms, the sacrifice of some cells can aid in the 
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survival of the whole. It was therefore surprising that many single-celled 
organisms also exhibit PCD features. These features have been described in 
protozoans (Jiménez-Ruiz et al., 2010; Kaczanowski et al., 2011), yeast 
(Madeo et al., 2004), algae (Darehshouri et al., 2008; Yordanova et al., 2012), 
and even bacteria (Engelberg-Kulka et al., 2006; Lewis, 2000; Tanouchi et al., 
2012). 
 
2.4.1 Apoptosis in mammalian cells 
PCD in mammalian cells has been extensively studied and multiple reviews 
have covered the various forms of PCD (Fink and Cookson, 2005; Fuchs and 
Steller, 2011; Han et al., 2011; Tsujimoto and Shimizu, 2005; Zamzami and 
Kroemer, 2003). Apoptosis, by far the best understood of the many types of 
PCD, is mediated by a proteolytic cascade involving initiator and executioner 
caspases. Well-characterized features of apoptosis include membrane 
blebbing, DNA fragmentation, loss of mitochondrial membrane potential, and 
inversion of phosphatidylserine (PS) with intact plasma membrane. Caspases 
are highly conserved cysteine proteases that cleave proteins after an aspartic 
acid residue. They are synthesized as inactive precursors with an N-terminal 
prodomain, and a C-terminal protease domain that includes the p10 and p20 
subunits; excision of this prodomain and cleavage between the p10 and p20 
subunits result in p10/p20 heterodimers that are catalytically active 
(Hengartner, 2000). More than 280 substrates of caspases have been identified 




Apoptosis can be triggered by an extrinsic or intrinsic event, both of which 
lead to activation of the executioner caspases 3, 6, and 7. In the extrinsic 
pathway, apoptosis is initiated by proapoptotic ligand binding to death 
receptors at the cell plasma membrane leading to receptor aggregation. This 
enables the intracellular death domains of these receptors to recruit 
cytoplasmic adaptor proteins which each in turn bind to procaspase 8, forming 
the death-inducing signalling complex (DISC). Auto-catalytic processing of 
procaspase 8 to its active form, caspase 8, is induced by its homo-
oligopolymerization at the DISC. Alternatively, recruitment of another 
protein, c-FLIPL, can activate procaspase 8. In the cytosol, caspase 8 proceeds 
to activate the executioner caspases. In the intrinsic (or mitochondrial) 
pathway of apoptosis, various cytotoxic or proapoptotic stimuli result in 
mitochondrial outer membrane permeabilization (MOMP). The best known 
activator of intrinsic apoptosis is probably the tumour suppressor p53. This 
protein is a transcription factor that controls the expression of the proapoptotic 
members of the Bcl-2 protein family such as Bax, Bak, Bid, Puma, and Noxa. 
Cellular insults such as DNA breaks, oxidative stress, and aberrant progression 
past cell cycle checkpoints lead to disruption of p53 ubiquitination, 
suppressing p53 degradation and therefore raising levels of p53 in the cell. 
Antirepression of p53’s transcriptional promotion functions may also 
contribute to p53 activity (Brooks and Gu, 2010). Pro-survival members of the 
Bcl-2 family such as Bcl-2 itself, Bcl-XL, and Mcl-1 serve to capture and 
inactivate pro-apoptotic factors like Bax and Bak. Upon activation, p53 
upregulates Bax and BH3-only proteins that inactivate pro-survival Bcl-2 
members, while also activating Bak at the mitochondria (Fridman and Lowe, 
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2003; Leu et al., 2004). Bax and Bak both function by oligomerizing and 
forming large pores on the mitochondrial outer membrane, resulting in the 
opening of the mitochondrial “poison cabinet” and freeing multiple mediators 
of apoptosis into the cytosol. One of these proteins, cytochrome c, is part of 
the electron transport chain in healthy cells but in the cytosol serves to recruit 
multiple molecules of Apaf-1 and procaspase 9 into a complex known as the 
apoptosome. Procaspase 9 is thus activated similarly to procaspase 8, and 
proceeds to activate the executioner caspases. Although these pathways are 
often presented as distinct and separate, there is significant crosstalk between 
them (Roy and Nicholson, 2000). A third, specialized perforin/granzyme 
apoptosis pathway utilized by the immune system has also been proposed 
(Elmore, 2007). 
 
Caspase 3 is the most important of the executioner caspases. Upon activation, 
it cleaves a large number of targets, many of which lead to the classical 
features of apoptosis. For example, caspase 3 degrades the DNase inhibitor 
ICAD, freeing the endonuclease CAD to mediate the DNA fragmentation seen 
in apoptosis. Cytoskeletal proteins are also degraded and result in plasma 
membrane blebbing. Other targets include the Golgi apparatus, endoplasmic 
reticulum, and nuclear lamina in the nucleus, resulting in the disassembly of 
these organelles. 
 
2.4.2 PCD in other organisms 
Although the vast majority of PCD literature focuses on mammal and animal 
systems, P. falciparum is more closely related to algae and plants than 
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animals. Molecular evidence shows that apicomplexans (which include P. 
falciparum) and dinoflagellates are descended from a red algal ancestor, which 
are likely closely related to plants and green algae (Chan et al., 2011; 
Janouškovec et al., 2010; Moreira et al., 2000; Rodríguez-Ezpeleta et al., 
2005). As such, it may be fruitful to look into reports of PCD in these 
organisms too. Plants, fungi, and protozoa do not have caspases. Instead, they 
harbour an orthologous family known as metacaspases (Uren et al., 2000). 
Whether metacaspases are truly caspases is a matter of contention, given their 
homology and differing substrate specificities; metacaspases are cysteine 
proteases that cleave at an arginine residue instead of aspartic acid (Carmona-
Gutierrez et al., 2010; Enoksson and Salvesen, 2010; Vercammen et al., 2007). 
Regardless, whether metacaspases can mediate cell death is a different issue. 
PCD in the freshwater dinoflagellate Peridinium gatunense was described 
more than a decade ago. In P. gatunense, insufficient CO2 during 
photosynthesis led to a mode of cell death mediated by H2O2, which was 
mitigated by treatment with the broadly-acting cysteine protease inhibitor E-
64 (Vardi et al., 1999). Further similarities to apoptosis were noted in the 
unicellular algae Dunaliella tertiolecta. When kept in the dark, the algae 
exhibited hallmarks of apoptosis such as chromatin margination, disintegration 
of the nucleus, DNA fragmentation and increased caspase-like activity. 
Specific caspase inhibitors were able to abrogate these phenotypes (Segovia et 
al., 2003). In the marine diatom Thalassiosira pseudonana, iron starvation 
induced PS exposure and caspase-like activity as assessed by annexin V and 
CaspACE staining respectively. This correlated with upregulation of several 
metacaspase genes. Application of a pancaspase inhibitor z-VAD-fmk was 
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able to rescue these cells from death (Bidle and Bender, 2008). Clearly, the 
lack of caspases found in metazoa do not imply the absence of a regulated 
form of cell death. Other than caspase-like activity, several other lines of 
molecular evidence point to PCD in these organisms. A homologue of the 
proapoptotic protein Apaf-1 has been found to be upregulated in the green 
algae Chlamydomonas reinhardtii during UV-C exposure-stimulated cell 
death, connected to repression of a gene for an anti-apoptotic homologue dad1 
(Moharikar et al., 2007). Another marker in mammalian apoptosis is the DNA 
repair protein PARP-1, which is cleaved during apoptosis; however, it must be 
noted that PARP-1 cleavage has also been observed in necrotic cells (Gobeil et 
al., 2001; Soldani and Scovassi, 2002). Degradation of PARP-1 suppresses the 
utilization of ATP in poly(ADP-ribosyl)ation needed in sensing of DNA single 
strand breaks, freeing up ATP for the active processes required in apoptosis 
(Herceg and Wang, 1999; Los et al., 2002). Interestingly, in plants PARP 
appears to mediate PCD instead. PARP inhibition reduced H2O2-induced PCD 
in soybeans, and enhanced growth in Arabidopsis thaliana (Amor et al., 1998; 
Schulz et al., 2014). In C. reinhardtii, however, PARP-1 cleavage was 
observed when cells were treated with either H2O2 or the PCD inducer 
menadione, along with other apoptotic phenotypes such as disruption of 
mitochondrial membrane potential, increase in caspase-3-like activity, and 
DNA fragmentation (Sirisha et al., 2014; Vavilala et al., 2015). Interestingly, 
membrane blebbing, a characteristic phenotype of apoptosis in metazoa, was 
not reported in these photosynthetic unicellular organisms. Instead, death 
occurs through cell lysis. Blebbing could be specific to metazoa with immune 




2.4.3 Clues to PCD in Plasmodium 
In 1997, apoptosis was first proposed as a means by which CQ kills the 
erythrocytic stage parasite in humans based on the observation of DNA 
laddering, a classical apoptotic feature, after treatment of in vitro blood 
cultures with CQ (Picot et al., 1997). This turned out to be a controversial 
finding: some were unable to replicate it while others seemingly detected low 
amounts of DNA fragmentation with terminal deoxynucleotidyl transferase 
dUTP nick end labeling, or TUNEL (Ch’ng et al., 2010; Meslin et al., 2007; 
Nyakeriga et al., 2006; Totino et al., 2008). However, spurred by this initial 
finding, another classical apoptotic feature was discovered. In mammalian 
cells, loss of mitochondrial membrane potential (ΔΨm) is an early event in the 
intrinsic PCD cascade (Ravagnan et al., 2002). This loss of ΔΨm has also been 
observed in P. falciparum cultures treated with low micromolar concentrations 
of CQ (Ch’ng et al., 2010). Oxidative damage through this mode of action 
may possibly account for the loss of ΔΨm, since, in mammalian cells, 
mitochondrial permeability transition can indeed be induced by oxidative 
stress; however, CQ-induced ΔΨm loss is mitigated by cotreatment with the 
pan-caspase inhibitor zVAD (Ch’ng et al., 2010), suggesting an enzymatic 
mode of action instead. It must be noted, though, that despite the similarities to 
mammalian apoptosis, these features were drug-induced and could possibly be 
artefactual. To address this, several groups have attempted to induce PCD with 
more physiological conditions such as elevated nitric oxide concentration and 
oxidative stress (Meslin et al., 2011; Nyakeriga et al., 2006; Totino et al., 
2008). However, results are conflicting and there appears to be no consensus 
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yet. Table 2.1 presents a selection of key papers regarding programmed cell 
death in erythrocytic stage P. falciparum. Other features of mammalian 
apoptosis such as blebbing and PS inversion are technically challenging to 
assess due to the intracellular nature of the parasite, with the presence of 
multiple membranes that act as physical barriers to the reagents commonly 
used in PCD assays. 
 
PCD in the liver stage of the parasite has not been as extensively studied, 
although TUNEL-stained parasites in infected liver cells have been observed 
with a mouse model (van de Sand et al., 2005). It is likely that autophagic cell 
death plays a role in this stage. In the autophagy model organism 
Saccharomyces cerevisiae, the functions of the ATG proteins have been well-
characterized (Klionsky et al., 2011; Levine and Klionsky, 2004). 
Homologues of these proteins have been found in Plasmodium, hinting at the 
existence of an autophagic pathway (Duszenko et al., 2011). Interestingly, 
only about 20% of liver-stage parasites survive to produce merozoites, 
motivating research into how and why the remaining 80% die (Eickel et al., 
2013). The morphological features of the dying parasites resemble that of 
autophagic cell death, with observations of multiply-membraned vesicles and 
vacuolization of the parasite, although the Plasmodium homologs of ATG8, 3 
and 7 appear to play no role in this process (Eickel et al., 2013). 
 
PCD in the mosquito stage of the Plasmodium life cycle is more strongly 
supported (Baton et al., 2008; Engelbrecht et al., 2012). In the mosquito stage 
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the parasite does not reside within a host cell, making it more amenable to the 






Table 2.1 Selected articles on PCD in erythrocytic stage P. falciparum 
Year Authors Parasite strain/ 
cell type 
Inducer of cell 
death 
PCD features assessed 
 
Assay used Proposed mechanism 
1997 Picot et al. (Picot et al., 1997) 3D7, Lili Chloroquine • DNA fragmentation (3D7 only) • Southern blot Apoptosis 
2006 Nyakeriga et al. 






• Loss of  ΔΨm (atovaquone induced) 
• DNA fragmentation (none) 
• DiOC6(3) 
• Electrophoresis, TUNEL  
Non-apoptotic cell 
death 
2007 Oakley et al. 
(Oakley et al., 
2007) 
3D7 Heat stress • Crisis forms (41 °C, 2 h in trophozoites and 
schizonts) 
• DNA fragmentation (41 °C, 2h in schizonts) 
• Giemsa smear 
• TUNEL 
Apoptosis 
2007 Meslin et al. 
(Meslin et al., 
2007) 
3D7, 7G8 Chloroquine • Loss of  ΔΨm (3D7, 7G8) 
• DNA fragmentation (3D7, 7G8) 





protein, PfMCA1  
2008 Kumar et al. 
(Kumar et al., 
2008) 
NF-54 Bilirubin • Loss of  ΔΨm (bilirubin) 
• Caspase 3-like DEVDase activity (bilirubin) 









2008 Totino et al. 





• Loss of  ΔΨm (chloroquine, SNAP, staurosporine) 
• DNA fragmentation (5-9% of dead parasites with 
all drugs) 
• Caspase inhibitor rescue (none) 









Dd2 High parasite 
density 
• Loss of  ΔΨm (high density cultures) 
• DNA fragmentation (high density cultures) 




• RT-PCR, Western blot 
Density-sensing 
2010 Pattanapanyasat et 





• Phosphatidylserine exposure* 
 











Year Authors Parasite strain/ 
cell type 
Inducer of cell 
death phenotype 
Features assessed 
(triggers in parentheses) 
Assay used Proposed mechanism 
2010 Ch’ng et al. (Ch’ng 





• Loss of  ΔΨm (chloroquine, staurosporine) 
• DNA fragmentation (chloroquine, staurosporine) 
• Cysteine protease activity (chloroquine, 
staurosporine) 





• Protease inhibitors 
Activation of clan CA 
proteases 
2011 Meslin et al. 







• Phosphatidylserine exposure 
• Caspase inhibitor rescue 
• Annexin V 
• Propidium iodide 
• Z-VAD-fmk 
Metacaspase-like 
protein, PfMCA1  
2011 Ch’ng et al. 
(Ch’Ng et al., 
2011) 
3D7, 7G8, K1 Chloroquine • Rescue of ΔΨm loss (none) or DNA fragmentation 
(BAPTA, cycloheximide, actinomycin D) 
• Pre-procathepsin c upregulated 
• Pre-procathepsin c knockout could not rescue 
PCD features  
• Array of specific inhibitors 




• Gene knockout 
Release of DV 
proteins into the 
cytosol 
2011 Rathore et al. 
(Rathore et al., 
2011) 
3D7 Peptide inhibitor • Loss of  ΔΨm (peptide-treated) 
• Cysteine protease activity (peptide-treated) 











3D7 Heat stress • DNA fragmentation (41 °C, 2 h in early stage)  
• Loss of  ΔΨm (40 °C, 24 h in early stage) 
• Phosphatidylserine exposure* (41 °C, 2 h in late 
stage) 
• Vacuolization (41 °C, 2 h in early and late stages) 
• TUNEL 
• DiOC6(3) 
• Annexin V 








3D7 Sunlight • DNA fragmentation 
• Mitochondrial hyperpolarization 
• No phosphatidylserine inversion* 
• TUNEL 
• DiOC6(3) 
• Annexin V 
Sunlight-mediated 
generation of reactive 
oxygen species 
 
* Phosphatidylserine inversion in the parasite was assessed without a control for plasma membrane integrity 
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PS externalization, alteration of mitochondria membrane potential, CaspaTag 
staining and blebbing-like morphologies have been reported in the ookinetes, 
with rescue of apoptosis through the application of caspase inhibitors (Al-
Olayan et al., 2002; Arambage et al., 2009). This occurred even in standard 
culturing conditions without the application of chemical inducers (Arambage 
et al., 2009). Physiological triggers of apoptosis in this stage may include 
nitric oxide and reactive oxygen species (Ali et al., 2010). 
 
2.4.4 Mechanisms of death 
P. falciparum lacks caspases, but its genome codes for putative metacaspases 
(Meslin et al., 2007). There is uncertainty as to whether metacaspases function 
like caspases (Carmona-Gutierrez et al., 2010; Vercammen et al., 2007). In 
spite of this, a role for the P. falciparum metacaspase PfMCA1 in PCD was 
proposed based on sequence analyses of the putative genes (Meslin et al., 
2007). However, through the rescue of PCD features with specific protease 
inhibitors, clan CA proteases but not clan CD were implicated in the 
manifestation of these features upon drug treatment (Ch’ng et al., 2010). The 
clan CA proteases present in P. falciparum are the falcipains, calpains and 
cathepsins, whereas metacaspases are clan CD (Cambra et al., 2010; Carmona-
Gutierrez et al., 2010; Rosenthal, 2011; Soh et al., 2013), casting uncertainty 
on the hypothesis that PfMCA1 mediates PCD. Further work showed that 
permeabilization of the DV in the trophozoite stage appears to be an early 
event in CQ-induced cell death, with pre-procathepsin c upregulation as a late 
event - however, knockout of pre-procathepsin c did not rescue the parasites 
from these PCD features (Ch’ng et al., 2011). In contrast, the ability of the 
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metacaspase PfMCA1 to induce apoptosis has been demonstrated, albeit in 
yeast models (Meslin et al., 2011). Because Plasmodium resides within the 
erythrocyte throughout most of the asexual stage, it is not amenable to annexin 
V staining. The use of a yeast model bypasses this constraint. Surprisingly, 
although previous studies with P. falciparum showed that nitric oxide donors 
do not induce apoptosis-like death (Nyakeriga et al., 2006; Totino et al., 
2008), oxidative stress via the application of H2O2 could trigger apoptosis in 
yeast transfected solely with PfMCA1 (Meslin et al., 2011). However, even if 
apoptosis in the transfected yeast can clearly be attributed to PfMCA1, this 
protease may not play the same role in the parasite. The parasite genome also 
encodes for a putative apoptosis-related protein, PfARP (Guha et al., 2007). 
This protein appears to be homologous to the mammalian TFAR19, which 
plays a pro-apoptotic role (Liu et al., 1999). 
 
At the mitochondrion, disrupting the interactions between PfClpQ and PfClpY 
(homologs of the bacterial protease components ClpQ and ClpY respectively) 
with a peptide resembling the binding domains resulted in an apoptotic 
phenotype (Rathore et al., 2011). It is not known whether this dissociation 
occurs physiologically, although it is an attractive drug target. Speculatively, 
one might imagine that PfMCA1 or a clan CA protease could interfere with 
this protein complex, resulting in the observed PCD features. Not enough is 




2.4.5 Adaptationist hypotheses for the evolution of PCD 
In multicellular organisms, PCD plays well-documented roles in the 
development, maintenance, and defense of the organism (Kerr et al., 1972). In 
these organisms, PCD is readily explained by the fact that an organism’s cells 
are clonally related and so share the same goal in the survival and maintenance 
of the organism (Reece et al., 2011). However, there has been increasing 
evidence of PCD in unicellular protozoan parasites, leading to interesting 
questions of why these parasites would encode for a suicide pathway (Reece et 
al., 2011). This section discusses the reasons that PCD may have evolved in 
the malaria parasite. 
 
In malaria holoendemic regions, the local population is generally infected at 
an early age. Naive individuals are almost always symptomatic upon infection 
(Doolan et al., 2009), such that the burden of malaria falls heaviest on the 
young - in fact, 70% of global malaria deaths in 2015 accrue to children under 
the age of five (World Health Organization, 2015). Initial infection results in a 
period of peak parasitemia associated with disease, after which parasitemia is 
suppressed and maintained at low levels for the remaining life of the host. This 
maintenance of asymptomatic chronic infection is presumably a result of 
repeated exposure of the host immune system to a variety of Plasmodium 
strains and antigens, leading to strain-transcending non-sterilizing immunity 
(premunition) (Doolan et al., 2009; Pérignon et al., 1994). However, in 
instances of parasite elimination from the host such as through chemotherapy 
or removal of the patient from malaria-endemic regions, premunition is 
rapidly lost (Eling, 1980; Trape et al., 2011) - this is unexpected if 
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premunition is solely the result of acquired immunity since immunological 
memory typically lasts for decades (Gourley et al., 2004). Adding to this, a 
longitudinal study of Javanese migrants in Indonesian Papua indicated that 
anti-malarial immunity does not require the many years of exposure to 
Plasmodium as previously thought. In this study, 243 subjects were followed 
for 33 months after they moved to a malaria-endemic region of Indonesian 
Guinea (Krisin et al., 2003). Although both adults and children were initially 
equally susceptible to infection, suppression of parasitemia in the adult group 
was observed after only 20 months, contrary to the belief that anti-parasite 
immunity requires years of exposure (Doolan et al., 2009). Premunition 
therefore hints at the possibility that immunity is mediated directly by the 
parasites instead of solely through the maturation of adaptive immunity.  
 
It has been suggested that parasite PCD could be a mechanism by which the 
parasite limits its numbers and thus virulence, such that the host (whether 
human or mosquito) survives and serves as a reservoir for new infections 
(Pollitt et al., 2010; Reece et al., 2011). If so, the proposition that premunition 
is a function of the immune response may be incomplete - premunition could 
also be partly due to parasite quorum sensing. Supporting this hypothesis, in 
an in vitro study, parasite density appeared to be controlled despite the 
absence of an adaptive immunological mechanism. In P. falciparum blood 
cultures, parasitemia was limited to about 5% despite daily changes of culture 
medium, exhibiting characteristics similar to apoptosis such as DNA 
fragmentation and ΔΨm loss (Mutai and Waitumbi, 2010). Adding to this, a 
method was devised to culture P. falciparum to a high parasitemia through the 
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use of a hollow-fibre capillary bioreactor. This apparatus traps the cells 
between semipermeable fibres while circulating culture medium in a closed 
system. The authors report that attainment of high parasitemia appeared to be 
hampered by unidentified proteins secreted by the parasites (Li et al., 2003). 
However, it is difficult to extricate nutrient starvation from quorum sensing in 
these cultures especially if signaling molecules are removed by medium 
changes. Furthermore, ΔΨm loss and TUNEL staining were taken as proxies 
for PCD (Mutai and Waitumbi, 2010). These are indeed common assessments 
of mammalian PCD, but may also manifest in late stages of other forms of 
death such as necrosis (Kraupp et al., 1995; Lemasters et al., 1998). These 
assays may therefore be inappropriate to detect PCD in continuous cultures 
which may contain parasites at any stage of death. 
 
2.4.6 Regulated or incidental cell death? 
The biochemical characteristics of P. falciparum death vary depending on how 
the parasite is killed. It is undeniable that certain modes of death exhibit 
features reminiscent of programmed cell death in metazoa. However, the 
molecular pathways leading to these death phenotypes have yet to be 
elucidated. In light of this, Proto et al. (2013) propose that the term “incidental 
cell death” be used instead, until the burden of evidence for a regulated 
molecular pathway has been satisfied. This author is in agreement; the 
literature has yet to demonstrate a programmed pathway, i.e., one that is 
encoded in the genome of the parasite. This is made clear in the fact that 
effectors of cell death have yet to be validated, be they metacaspases or other 
proteins. Neither has any form of regulation been established, such as by 
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rescuing the parasite from death through the overexpression of death-
inhibiting proteins. In addition, the relevance of any such pathway to the life 
cycle of the parasite must be demonstrated. 
 
However, in the blood stage of P. falciparum, the parasite has evolved to 
reside in and is dependent upon the host RBC. This view of the parasite in 
relation to its environs allows one to speculate that the parasite need not 
encode a death pathway in its genome; co-opting of host pathways may be an 
alternative to effecting cell death, in a manner not dissimilar to viruses 
inducing apoptosis in mammalian cells. The burden of evidence thus shifts 
away from the “programmed” nature of cell death (mechanisms of death need 
not be encoded in the parasite genome), and towards regulation of host-
encoded pathways. This may explain the elusive nature of cell death effectors 
in the parasite, despite the PCD-like features. Mature human erythrocytes 
retain an intact apoptosis pathway with caspases 8 and 3; this pathway has 
been implicated in PS externalization in oxidatively-stressed RBCs (Bratosin 
et al., 2009; Mandal et al., 2005). Furthermore, RBCs may also initiate a Ca2+-
induced, calpain-mediated death pathway known as eryptosis (Bratosin et al., 
2001; Lang and Lang, 2015). By regarding the parasite and its obligate host 
erythrocyte as a singular entity, induction of these pathways by the parasite 
can constitute PCD of the parasite.           
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3. A high-content screen for the 




A DV-localizing fluorescent dye Fluo-4 can serve as an indicator of DV 
permeabilization, in that DV disruption results in the dispersion of the dye into 
the parasite cytosol. Downstream of DV permeabilization, the parasite exhibits 
DNA degradation and loss of ΔΨm, phenotypes similar to mammalian 
apoptosis (Ch’ng et al., 2011). This mode of cell death may prove to be 
fruitful in drug development. To do so, however, requires that it be amenable 
to efficient and cost-effective screens, both to validate the utility of this 
phenotype and to uncover new compounds that exploit this pathway. 
However, the traditional fluorescent microscopy used to detect Fluo-4 
redistribution is laborious and prone to bias, limiting its usefulness as a tool 
for drug screening. Imaging flow cytometry allows one to bypass these 
limitations by combining a relatively high throughput with the high-content 
image readouts in a non-biased manner (Basiji et al., 2007). This chapter 
describes the use of the ImageStream 100 imaging flow cytometer to detect 
the redistribution of Fluo-4 as a screen for novel DV-disrupting compounds, 
and the validation of those hits. Figures reproduced from Lee et al. (2014) and 





3.2 Methods and materials 
Detailed methods and materials for this section can be found in Lee et al. 
(2016). A schema of the workflow is presented in Figure 3.1. 
 
3.2.1 Culture of parasites 
P. falciparum strains 3D7, 7G8, and K1 as well as the clinical isolates SMRU 
0233, SMRU 0272, SMRU 0270, and SMRU 1116 were cultured in malaria 
culture medium (MCM) with purified human RBCs added to 1.25% or 2.5% 
hematocrit. MCM comprises RPMI 1640 powder without sodium bicarbonate 
(Gibco) supplemented with 2.2 g/l sodium bicarbonate, 0.5% Albumax II (Life 
Technologies), 0.005% (w/v) hypoxanthine, 0.03% (w/v) L-glutamate, and 25 
μg/l gentamicin. Hypoxanthine was dissolved in a small amount of 1 N NaOH 
(approximately 500 μl) prior to adding to the solution. The pH of the MCM 
was adjusted to 7.4 by the addition of 1 N NaOH. The MCM was then filter-
sterilized in a vacuum filter unit of 0.22 μm pore size and stored at 4 °C for up 
to a month. RBCs were obtained from donors who provided informed consent 
and were purified by centrifugation and aspiration of the buffy coat. The 
purified RBCs were stored in citrate-phosphate-dextrose-adenine (CPDA) 
solution for at least 4 days at 4 °C as previously reported (Beutler and West, 
1979); RBCs were then washed in RPMI 1640, stored in MCM at 50% 
hematocrit and 4 °C, and used within a month from blood draw. Parasite 
cultures were gassed with a mixture of 5% CO2, 3% O2, and 92% N2 and 
incubated at 37 °C in the dark. Parasitemia and stage of the parasites were 
assessed by methanol fixation of thin smears and staining with 15 % Giemsa 
solution for 5 min, followed by viewing under a light microscope with the oil 
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immersion 100× objective; at least 600 RBCs were counted for each 
assessment. The clinical isolates were a kind gift from Dr François Nosten. 
 
3.2.2 Synchronization of parasites 
Parasite cultures were synchronized by resuspension in 5% (w/v) D-sorbitol. 
The suspension was vortexed vigorously for 30 s, incubated at 37 °C for 10 
min, and vortexed again for 15 s. The cells were then pelleted by 
centrifugation and washed with RPMI before returning to culture conditions as 
described in section 3.2.1. When required, parasite cultures were incubated at 
room temperature to retard the growth of the parasites so as to attain the right 
stage for experiments. Use of temperature control to maintain parasite 
synchronicity has been previously reported (Haynes and Moch, 2002). 
 
3.2.3 Growth inhibition assay 
Ring-stage parasites at 1-2% parasitemia at 1.25% hematocrit were incubated 
with serially-diluted compounds for 48 h at culture conditions. Cells were then 
stained with 1 μg/ml Hoechst 33342 for 30 min and parasitemia assessed by 
flow cytometry. The dose-response curves were plotted on Graphpad Prism 5 
and the half-maximal inhibitory concentrations (IC50s) thus determined. 
 
3.2.4 Treatment of parasites with candidate compounds for screening 
Parasites were cultured to approximately 10% parasitemia at about 32 h post-
infection (refer to Figure S3.1). Culture medium was then changed and 
cultures resuspended to 2.5% hematocrit. Compounds were diluted to 10× of 
the final test concentration in PBS; 20 μl of this stock solution was then added 
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to 180 μl of parasite culture in a sterile 96-well flat-bottomed plate. Care was 
taken to avoid generating bubbles. The plate was then placed in a humidified 
hypoxic chamber, flushed with culture gas mixture, and incubated at 37 °C. 
 
3.2.5 Staining of parasites for ImageStream analysis 
The 96-well plate was centrifuged at 800 × g for 1 min to pellet the cells. Cells 
were then resuspended twice in 200 μl of MCM to wash off the test 
compounds. Next, the cells were resuspended in MCM containing 1 μM Fluo-
4 AM and 1 μg/ml Hoechst 33342 and incubated at 37 °C in the dark for 30 
min. Single-stained controls were also obtained to facilitate the creation of the 
compensation matrix later on. Cells were then washed twice in 200 μl of PBS 
and resuspended in 100 μl of PBS. 
 
3.2.6 Acquisition with the ImageStream 100 
Cells were transferred to 600 μl microcentrifuge tubes and loaded onto the 
ImageStream 100 imaging flow cytometer (Amnis) fitted with a 40× objective. 
At least 300 events from each single-stained control was collected with the 
bright field switched off. For the samples, cells were acquired based on area of 
the bright field channel (between 50 and 500), and on mean fluorescence 
intensity in the Fluo-4 channel (between 50 and 500). At least 10 000 events 
were acquired for each sample. 
 
3.2.7 Analysis of ImageStream data 
Analysis was performed on the companion software IDEAS (ver. 4.0). 
Compensation matrices were generated from the single-stained controls by the 
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software and checked visually. Events were gated for a high aspect ratio in the 
bright field to exclude cells facing orthogonally from the imaging plane, and 
by area to select for single cells (Figure S3.2), followed by gating for in-focus 
cells. Hoechst fluorescence was then used to select for parasites in the 
trophozoite stage. From these parasites, the mean area of Fluo-4 fluorescence 
was measured. 
 
3.2.8 Confocal microscopy 
Parasites were treated and stained as in Sections 3.2.3 and 3.2.4 and were 
loaded as wet mounts. The cells were then visualized on the Olympus 
Fluoview FV1000 confocal microscope under the 100× objective. 
Fluorophores were excited by lasers tuned to 405 nm and 488 nm for Hoechst 
and Fluo-4 respectively. Parasites were chosen based on the differential 
interference contrast (DIC) imaging and acquired without observing Fluo-4 or 
Hoechst staining. Cells were then enumerated and classed as DV-intact, DV-
disrupted or low/no fluorescence. 
 
3.2.9 Assessment of PCD-like features 
Parasites at the early-mid trophozoite stage at 10-15% parasitemia were 
treated for 10 h with the compounds then stained with 0.8 μg/ml Hoechst 
33342 and 6 μM of the ΔΨm indicator JC-1 (Life Technologies) in MCM for 
30 min at 37 °C in the dark. Cells were then washed twice and resuspended in 
PBS for analysis on the BD LSR II flow cytometer. DNA degradation was 
assessed by defining the first decile of the DNA-positive events in the control 




Figure 3.1 Schema of the DV disruption screening assay. Parasite cultures were 
treated with candidate compounds for 4 h, then stained with Hoechst 33342 and Fluo-
4 AM. Cells were then loaded and analysed on the ImageStream 100. Round, in-focus 
cells were selected by gating on bright field images. Hoechst staining was then used 
to select trophozoite-stage parasites. From these parasites, the mean area of Fluo-4 
fluorescence was measured and compared to that of the vehicle-control parasites. Hits 
were then validated by confocal microscopy. Arrowheads indicate the DV. DIC: 
differential interference contrast. 
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the use of Hoechst 33342 to detect a sub-G1 population has also been 
previously reported (Darzynkiewicz et al., 1992). The proportion of cells with 
intact mitochondria was taken as the proportion of Hoechst-positive events 
that are fluorescent in the red channel; this is then normalized to the vehicle 
control sample. 
 
3.2.10 Statistical analyses 
All statistical were performed in Microsoft Excel 2013 (t-tests) or IBM SPSS 





3.3.1 Growth inhibition of candidate compounds. 
A total of 25 compounds were selected for the screen. Of these, 17 were from 
the LOPAC (Library of Pharmalogically Active Compounds; Sigma-Aldrich) 
and were previously found to have antimalarial activity (Lucumi et al., 2010). 
Of the remainder, MQ, halofantrine, artemisinin, and sulfadoxine are used 
clinically for the treatment of malaria. These compounds were included to 
assess if DV disruption contributes to their antimalarial potency. 
Chlorpheniramine, propranolol, ciprofloxacin, and miltefosine are not used as 
treatments for malaria but exhibit potency against the parasite in vitro; they do 
not induce DV disruption (Ch’ng et al., 2011) and were included as controls. 
Prior to screening, these drugs were assessed for their growth inhibition of 
3D7 P. falciparum in vitro. Data are presented in Table 3.1 as half-maximal 
inhibitory concentration (IC50); this is the concentration of the compound 
required to exert half the maximum inhibition achievable of parasite 
reinvasion in a 48 h assay. Notably, the IC50 of sulfadoxine could not be 
determined within the range of concentration tested as 3D7 is a sulfadoxine-
resistant strain (Nzila and Mwai, 2010). The antimalarial potency of all other 
compounds are thus confirmed, albeit some at high concentrations. 
 
3.3.2 Screening of compounds on the imaging flow cytometer 
Next, parasites were treated with 10 μM of the candidate compounds for 4 h 
and analysed on a high-content system, namely the ImageStream 100 imaging 
flow cytometer. This system essentially combines flow cytometry with a high-
speed camera, capturing images of individual cells as they pass through the 
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Table 3.1 Growth inhibition of candidate compounds on 3D7 
Drug (abbreviation)  IC50 (nM) 
Vincristine      (VC)  5 
Halofantrine      (HF)  5 
Vinblastine      (VB)  9 
Mefloquine      (MQ)  11 
Quinidine      (QUD)  25 
Benzamil      (BEN)  27 
Emetine      (EME)  28 
Artemisinin      (ART)  30 
Chloroquine      (CQ)  46 
Cinchonine      (CIN)  48 
Quinacrine      (QC)  56 
Quinine      (QN)  62 
Hexahydro-sila-difenidol hydrochloride   (HEXA)  81 
3’,4’-dichlorobenzamil     (DCB)  90 
BW 284c51      (BIS)  360 
Amperoxide      (AMP)  866 
S(—)-UH-301      (UH301)  2,660 
5-(N-ethyl-N-isopropyl)amiloride   (a3085)  3,750 
SKF 95282      (SKF)  4,090 
Ciprofloxacin      (CIP)  4,400 
5-(N-methyl-N-isobutyl)amiloride   (A5585)  4,990 
5-(N,N-dimethyl)amiloride hydrochloride  (A4562)  6,590 
Propranolol      (PRO)  19,000 
Chlorpheniramine     (CPN)  33,700 
Miltefosine      (MTF)  70,000 
Sulfadoxine      (SUL)  > 105 





flow cell, recording both fluorescence and bright field data. As this provides 
additional spatial information in addition to the intensity data obtained from a 
typical flow cytometer, the area of fluorescence can be ascertained for each 
individual cell. Prior to loading onto the ImageStream 100, cells were stained 
with the DNA-binding dye Hoechst 33342 and the Ca2+ indicator Fluo-4 AM. 
Fluo-4 AM is a membrane-permeable dye that, upon entering the cell, is 
cleaved by esterases to Fluo-4, which then fluoresces upon binding to free 
Ca2+. The DV is a proposed Ca2+ store (Biagini et al., 2003), and in 3D7 Fluo-
4 localizes to this organelle. DV disruption redistributes Fluo-4 throughout the 
parasite cytosol, resulting in an enlarged area of Fluo-4 fluorescence (Ch’ng et 
al., 2011). The ImageStream system allows for the examination of thousands 
of cells per sample in several minutes, far surpassing the throughput of 
traditional fluorescence microscopy. Using the companion analysis software 
IDEAS, the mean area of Fluo-4 fluorescence could be determined for each 
sample. The results of the 10 μM screen are presented in Figure 3.2A; at this 
concentration, 16 compounds resulted in a significantly larger mean Fluo-4 
area than the vehicle control. These 16 compounds were then re-screened at 1 
μM to select for hits with high potency, and of these, three compounds 
significantly induced DV disruption (Figure 3.2B). However, although 
emetine treatment resulted in a significantly increased Fluo-4 area, the effect 
size of this treatment was small; emetine was therefore dropped from further 
validation. The other two hits were quinacrine (QC) and 3’,4’-






Figure 3.2 DV permeabilizing compounds identified through screen. (A) 
Candidate compounds were screened at 10 μM for DV permeabilization. CQ at 3 μM 
was used as a positive control in each run. Of the 25 compounds screened, 16 
compounds were significantly different from the vehicle control. (B) These 16 
compounds were then rescreened at a lower concentration of 1 μM. Of these, three 
were significantly different from the vehicle control: EME, DCB, and QC. Data 
presented represent mean fluorescence area of the Fluo-4 channel normalized to the 
vehicle control. Error bars represent standard error of the mean. Grey bars indicate 
treatments significantly different from the vehicle control at p < 0.05; n ≥ 3, paired t-
test. (C) Chemical structures of selected DV disruptors and non-disruptors. Red 










3.3.3 Validation of hits by confocal microscopy 
The same assay was validated by confocal microscopy to assess the utility of 
mean fluorescence area as an indicator of DV disruption. In addition to 3D7, 
the CQ-resistant laboratory strains 7G8 and K1 were also treated with the hits. 
Cells were then classed under confocal microscopy as DV-intact, DV-
disrupted, or low-to-no fluorescence. Representative confocal images can be 
seen in Figure 3.1. The proportion of parasites in each classification is 
presented in Figure 3.3. Both hits effectively induced DV permeabilization in 
the CQ-susceptible 3D7 strain, validating the results from the ImageStream 
assay. However, in the CQ-resistant strains 7G8 and K1, DCB was less potent 
and could only disrupt the DV at the highest-tested concentration of 10 μM. 
Similarly, although QC was able to significantly increase the proportion of 
DV-disrupted K1 parasites at 10 and 1 μM, it could not produce this effect at 
500 nM, unlike in 3D7. The CQ-resistant parasites may therefore be somewhat 
cross-resistant against the two hits. This is recapitulated in the growth 
inhibition assay; QC and DCB are less potent inhibitors of reinvasion in the 
CQ-resistant strains 7G8 and K1, although QC was less affected (Table 3.2). 
 
3.3.4 Induction of PCD-like phenotypes 
DV disruption is an upstream event of a PCD-like phenotype in 3D7, in 
particular DNA degradation and the loss of ΔΨm (Ch’ng et al., 2011). As such, 
the two hits were tested for the induction of these features. In addition, the 
CQ-resistant strains were included to assess the effect of CQ resistance on the 
manifestation of these features. Figure 3.4 shows how each strain responds to 







Figure 3.3 Validation of hits on laboratory strains by confocal microscopy. 3D7 
is a CQ-susceptible strain, whereas 7G8 and K1 are CQ-resistant. Panels A, B, and C 
show the response of 3D7, 7G8 and K1 respectively. Cells were treated similarly to 
the ImageStream-analysed cells, but were enumerated by confocal microscopy 
instead. Parasites were classed as DV-intact (black), DV-permeabilized (grey), or low 
to no fluorescence (white). Where not stated, the concentration of CQ used was 3 μM. 
*, p < 0.05; **, p < 0.01; ***, p < 0.001; Fisher’s exact test comparing intact DV 






Figure 3.4 Induction of PCD-like features in laboratory strains. Response of each 
strain to the three DV-disrupting compounds. Panels A, B, and C present the dose-
dependent induction of DNA degradation or mitochondrial depolarization in 3D7, 





Figure 3.5 Differential potential of hits to induce PCD-like phenotypes. The dose-
dependent induction of PCD-like features by CQ, QC, and DCB are presented in 










Strain or isolate 
 Resistance status  Mean IC50 (nM) 
 Chloroquine Artemisinin  CQ QC DCB 
Laboratory strain        
   3D7  Sensitive Sensitive  47 56 90 
   7G8  Resistant Sensitive  292 151 529 
   K1  Resistant Sensitive  569 100 679 
Field isolate 
    
       
   SMRU 0270  Resistant Sensitive  253 64 426 
   SMRU 1116  Resistant Sensitive  391 68 536 
   SMRU 0233  Resistant Resistant  139 75 551 
   SMRU 0272  Resistant Resistant  158 82 530 
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exhibiting DNA degradation and ΔΨm loss at the lower concentrations.   
However, the CQ-resistant 7G8 and K1 appear to be also resistant to DNA 
degradation induced by QC, while being resistant to mitochondrial 
depolarization by DCB. Figure 3.5 presents these data as the effect of each 
compound on the three strains instead. Here, it is clear that QC was able 
induce ΔΨm loss similarly in all three strains, despite the CQ cross-resistance 
noted previously. DCB, on the other hand, could only disrupt the mitochondria 
at high concentrations. Interestingly, DCB treatment resulted in DNA 
degradation in the resistant strains at high concentrations while QC, a more 
potent inhibitor of reinvasion, was not able to. However, as QC is a quinoline 
antimalarial, it likely has an additional mode of inhibition: by interfering with 
hemozoin formation, as discussed previously. Both DCB and QC potently 
induced DNA digestion and ΔΨm loss in the CQ-sensitive 3D7, which was 
expected as the DV-disruption screen was performed on 3D7. 
 
3.3.5 Potency of hits on clinical isolates 
The potency of these compounds to induce DV disruption was also tested in 
clinical isolates. Of these isolates, two were artemisinin-sensitive (SMRU 
0270 and SMRU 1116) while two were from patients exhibiting a delayed-
clearance profile (SMRU 0233 and SMRU 0272), defined as patients 
remaining parasitemic after 3 days of artemisinin-based treatment. The growth 
inhibition of these hits on the clinical isolates are presented in Table 3.2. In all 
four isolates, the hits were able to induce DV disruption at the highest 
concentration tested (Figure 3.6). QC was generally the more potent of the two 





Figure 3.6 Validation of DV-disrupting potency in clinical isolates. The potency 
of the hits to induce DV permeabilization was assessed in clinical isolates through 
confocal microscopy. Parasites were classed as DV-intact (black), DV-permeabilized 
(grey), or low to no fluorescence (white). ***, p < 0.001; **, p < 0.01; *, p < 0.05, 






at 500 nM in three of the four isolates. DCB was only effective at 10 μM for 
all isolates, probably due to CQ-cross resistance.  
 
3.3.6 Resolution of the ImageStream assay 
The strictly standardized mean difference (SSMD) score is a measure of the 
resolution of an assay, not dissimilar to the more-commonly reported Z-factor. 
The SSMD, however, allows the use of paired data in its calculation, and was 
calculated as previously reported (Zhang, 2008). Using paired vehicle and CQ 
control data from each run, the SSMD score of this assay was 2.62, which 




Presented in this chapter is a high-content assay that was able to detect Fluo-4 
redistribution as a result of drug treatment. From the initial panel of 25 
candidate compounds, we have identified two novel DV disruptors, QC and 
DCB.  
 
QC is an old antimalarial drug that is no longer in use, having been supplanted 
by CQ. As discussed previously, QC is a quinoline antimalarial and therefore 
believed to work similarly to CQ by inhibiting hemozoin formation. However, 
QC is not as well-characterized as CQ, and its mechanism of action is not 
firmly established. This screen provides evidence that DV disruption may be 
an alternative mode of action, and that QC is able to induce PCD-like features 
in the parasite. Furthermore, although some cross-resistance is apparent from 
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the CQ-resistant parasites 7G8 and K1, the IC50s of QC on these parasites 
were substantially lower than those of CQ. This raises the possibility of 
reintroducing QC as a prophylaxis against P. falciparum malaria. QC is also a 
known fluorophore and indeed exhibited slight fluorescence in the green 
channel on a flow cytometer (data not shown). This did not significantly affect 
our assay, particularly as the CQ-resistant strain K1 showed a large proportion 
of cells without redistributed green fluorescence. Other autofluorescent 
compounds however may pose a problem if drug-induced background 
fluorescence is too high. This author recommends either excluding these 
compounds through a preliminary screen for drug fluorescence, or modifying 
the analysis of fluorescence area to measure only the area of fluorescence 
beyond the intensity of the compound-induced background. 
 
DCB is an inhibitor of a Na+/Ca2+ exchanger in mammalian cells (Oda et al., 
2011; Renterghem and Frelin, 1993). This raises an important limitation of the 
ImageStream assay; compounds that inhibit transporters may possibly affect 
the apparent Fluo-4 localization. Fluo-4 is transported into the DV by 
PfMDR1, a transporter situated on the DV membrane (Friedrich et al., 2014; 
Rohrbach et al., 2006). Compounds that inhibit PfMDR1 and block Fluo-4 
influx could therefore result in cytosolic Fluo-4 and a false positive. 
Downstream validation steps such as the assays for DNA degradation and 
ΔΨm are hence essential. As Fluo-4 is a Ca2+ indicator and fluoresces when 
bound to free Ca2+, another possibility could be that Ca2+ influx into the DV 
may be disrupted, resulting in increased cytosolic Ca2+ levels. Residual Fluo-4 
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in the cytosol of the parasite may then fluoresce and again lead to a false 
positive. 
 
Here, the ImageStream assay was performed on 3D7. It must be noted that 
some variants of PfMDR1 do not transport Fluo-4 into the DV, resulting in 
cytosolic fluorescence without any drug stimuli (Rohrbach et al., 2006). If a 
different strain is used, DV localization of Fluo-4 should first be ascertained 










CQ is often studied at nanomolar doses in vitro (see for example Martiney et 
al. (1995)). Our laboratory showed that CQ at 3 μM for 4 h can induce 
permeabilization of the DV in the susceptible strain 3D7 (Ch’ng et al., 2011). 
This is generally considered a high dose and therefore there exists the question 
of whether DV disruption is physiologically relevant in patients as a CQ mode 
of action. Measuring CQ blood concentrations of adult volunteers who 
ingested a dose of 600 mg CQ (a standard initial therapeutic dose) showed that 
for most individuals, serum concentrations do not reach 3 μM. A single-dose 
regimen however is not typical; modelling the pharmacokinetics of a more 
typical 3-dose regimen illustrated that blood concentrations of 3 μM and 
above are not sustained throughout the treatment period. Most subjects in fact 
only achieve sustained blood CQ levels of 1 to 2 μM. However, with the long 
half-life of CQ (approximately 23 days), concentrations remain elevated for an 
extensive duration (Mzayek et al., 2007). In treatment of susceptible P. 
falciparum, a single dose of CQ was able to clear parasitemia rapidly 
(Hoekenga, 1952). Interestingly, at least in combination with sulfadoxine-
pyrimethamine or azithromycin, plasma concentrations of CQ peaked higher 
in pediatric patients (albeit at different doses) but were cleared faster (Obua et 
al., 2008; Zhao et al., 2014). As CQ was an exceptionally successful drug 
before resistance set in, identifying DV permeabilization as a heretofore 
unknown mechanism of CQ action may provide a measure of confidence that 
it is a viable phenomenon to exploit for drug development. Furthermore, 
return of CQ-susceptible P. falciparum has been reported in several parts of 
Africa where CQ has not been the treatment for P. falciparum malaria for 
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some time (Gharbi et al., 2013; Laufer et al., 2006; Mekonnen et al., 2014); 
this raises the possibility of reintroducing CQ as a first-line treatment in these 
regions. Therefore, this chapter explores the minimum duration and 
concentration of CQ required to achieve DV disruption using the assay 




4.2 Methods and materials 
3D7 and K1 parasite cultures and synchronizaton were performed as in 
Sections 3.2.1 and 3.2.2. 
 
4.2.1 Commitment to DV permeabilization 
Early trophozoite-stage parasites at 10 % parasitemia and 2.5 % hematocrit 
were treated with varying concentrations of chloroquine in MCM for different 
durations. Final volume of incubation was 200 μl and was performed in a 96-
well flat-bottomed plate in a hypoxic chamber at culture conditions. After 
treatment, cells were washed twice with 200 μl of MCM and further incubated 
up to a combined duration of 4 h to allow for DV rupture to occur. Cells were 
then stained similarly to Section 3.2.4 and analysed with the ImageStreamX 
Mark II imaging flow cytometer (Amnis). Samples were run on the 
autosampler in V-bottom plates, sealed with a pierceable adhesive film (X-
Pierce; Sigma) to reduce evaporation during the run. The flow cytometer was 
set to enable the extended depth of field (EDF) mode with the 60× objective 
on the low speed setting.  Fluorescent dyes were excited by the 375 and 488 
nm lasers and at least 2 000 Hoechst-positive events were acquired. On the 
companion IDEAS analysis software (version 6.1), only events with 
brightfield aspect ratios of 0.8 and above were included in the analysis to 
exclude orthogonally-facing RBCs that may compound the analysis, while 
also gating by area to select for single cells. The “Area” feature was used with 
the default mask on the green channel to quantify the area of Fluo-4 
fluorescence as a marker of DV disruption. A schema of the experiment 








Figure 4.1 Schema of the commitment experiments. Parasites were treated and 
allowed to further incubate up to the total durations of 4, 10, and 34 h before 
assessment for DV disruption, PCD-like features and inhibition of reinvasion 
respectively. (A) General outline of the commitment experiments. Cells were treated 
with CQ for a specific duration and were allowed up to the total duration for the 
phenotypes to develop. (B) An example of the commitment to DV disruption 
experiment. Parasites were treated with CQ for 1 h and incubated for a further 3 h (up 
to a total duration of 4 h) before staining and analysis. 
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4.2.2 Commitment to ΔΨm loss and DNA degradation 
Parasites were treated similarly as in section 4.2.1, except that the total 
duration of treatment with further incubation is 10 h instead of 4 h to allow for 
downstream features to manifest. Cells were then stained with 6 μM of the 
ΔΨm indicator JC-1 (Life Technologies) and 1 μg/ml Hoechst 33342 in MCM 
for 30 min at 37 °C. Cells were then run through the CyAn ADP flow 
cytometer (Beckman Coulter) and at least 100 000 events were acquired. 
Parasites were gated as events positive for Hoechst staining. DNA degradation 
and mitochondrial depolarization were assessed similarly in Section 3.2.8. 
 
4.2.3 Cytocidal effects of CQ pulse 
Parasite cultures at 5% parasitemia were treated similarly as in section 3.2.3, 
but were further incubated to a total of 34 h to allow for reinvasion to occur. 
Cells were then stained with 1 μg/ml Hoechst 33342 as before and parasitemia 
was assessed by flow cytometry on the CyAn ADP. 
 
4.2.4 Statistical analyses 
All statistical were performed in Microsoft Excel 2013 (t-tests) or IBM SPSS 





4.3.1 Induction of DV disruption in 3D7 
The CQ-susceptible strain 3D7 was pulsed with CQ and disruption of the DV 
was assessed with the ImageStream assay. This phenomenon is clearly 
concentration-dependent, as the area of Fluo-4 fluorescence increased with 
increasing CQ concentration (Figure 4.2A). Interestingly, although previous 
work suggests that DV disruption takes approximately 3.5 h to occur at a high 
concentration of CQ (Ch’ng et al., 2011), there was no apparent effect of 
varying the duration of CQ treatment (Figure 4.2B). The parasite was already 
committed to DV disruption with 1 h of CQ incubation, implying that even 
shorter pulses of CQ would be effective. This is consistent with reports on CQ 
uptake; CQ accumulation is rapid and usually measured within 1 h (Fitch, 
1969; Lehane et al., 2011). DV disruption therefore appears not to solely be a 
function of CQ accumulation but also involves downstream processes, such 
that the phenomenon occurs several hours after CQ treatment. Interestingly, 
CQ has been demonstrated to induce peroxidative cleavage of phospholipid 
membranes in conjunction with heme in a time-dependent manner (Sugioka et 
al., 1987). This may account for the delayed phenotype observed. Statistically 
significant results (paired t-test against vehicle control, p < 0.05) were 
achieved at 1 μM for the lowest duration tested (1 h), and were not detect at 
concentrations below 1 μM for all durations. 
 
4.3.2 Induction of PCD-like features in 3D7 
Similar to DV disruption, DNA degradation appeared to be dose-dependent 




    
 
Figure 4.2 DV disruption occurs within physiological parameters in 3D7. The 
CQ-susceptible strain 3D7 was subjected CQ treatment to assess the required doses 
and durations for DV disruption. (A) Concentration-dependence of DV disruption. 
(B) Duration-dependence of DV disruption. Total duration for this assay was 4 h. 
Area of Fluo-4 fluorescence was normalized to the vehicle control within each 























































































   
 
Figure 4.3 DNA degradation occurs within physiological parameters in 3D7. (A) 
Concentration-dependence of DNA degradation. (B) Duration-dependence of DNA 
degradation. Total duration for this assay was 10 h. The sub-G1 population was 
determined by gating on the bottom decile of the vehicle control in each duration set. 
























































































Figure 4.4 ΔΨm loss occurs within physiological parameters in 3D7. (A) 
Concentration-dependence of mitochondrial depolarization. (B) Duration-dependence 
of mitochondrial depolarization. Total duration for this assay was 10 h. Data 



























































































Figure 4.5 3D7 is exquisitely susceptible to CQ. The cytocidal effect of CQ was 
assessed by drug pulse. (A) Concentration-dependence of CQ killing. (B) Duration-
dependence of CQ killing. Total duration for this assay was 34 h. Data represent 









































































Figure 4.6 Correlation of DV disruption to cell death and PCD-like features in 
3D7. The relationships between DV disruption and cell death, DNA degradation, and 
mitochondrial depolarization are presented in panels A, B, and C respectively. 
Spearman’s rank correlation coefficient (ρ) of each relationship is presented beside 





















































































Normalized mean area of Fluo-4 fluorescence
ρ = -0.743 
ρ = 0.910 








Figure 4.7 Correlation of PCD-like features to cell death in 3D7. The relationships 
between cell death and DNA degradation or mitochondrial depolarization are 
presented in panels A or B respectively. Note that for panel B, the x-axis has been 
inverted to show the similarity in trend to panel A. Spearman’s rank correlation 
coefficient (ρ) of each relationship is presented beside each plot. All correlations 
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duration tested (1 h), results were significantly different from the vehicle 
control (paired t-test as above) at 500 nM. However, for ΔΨm loss, the effects 
of chloroquine appear to be both concentration- and duration-dependent 
(Figure 4.4), implying a different trigger than DNA degradation. For ΔΨm 
loss, statistical significance was achieved for 1 h treatment duration at 2 μM, 
while 1 μM treatment required 2 h to reach statistical significance. 
 
4.3.3 Cidality of CQ in 3D7 
Drug potency against P. falciparum is usually assessed by continuous 
incubation with the drug. However, this does not distinguish between 
cytostatic and cytocidal outcomes. Washing off of the test compound and 
providing time for reinvasion has been previously proposed as a measure of 
cidality (Paguio et al., 2011). Here, CQ killing is investigated in a similar 
manner. The cytotoxicity of CQ is distinctly concentration-dependent (Figure 
4.5A), and only somewhat dependent on the duration of treatment for the 
lower concentrations (Figure 4.5B). For 1 h treatments, 500 nM of CQ 
resulted in a statistically significant difference. Interestingly, while the CQ 
IC50 in a cytostatic assay is in the low nanomolar range (Table 3.2), here even 
a CQ concentration of 100 nM was unable to observably decrease cell 
viability. 
 
4.3.4 Correlations in 3D7 
Although DV disruption was proposed as an inducer of PCD features (Ch’ng 
et al., 2011), evidence is lacking that DV disruption does indeed kill the 
parasite. Figure 4.6A shows the correlation between DV disruption and CQ 
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killing of 3D7, by representing the data discussed previously on the same plot. 
DV disruption is denoted by the area of Fluo-4 fluorescence, normalized to the 
vehicle control at 100%. Clearly, a rapid decrease in parasite viability 
occurred as Fluo-4 fluorescence area increased beyond 100%, demonstrating 
that Fluo-4 relocalization is a good indicator of the cytocidal activity of CQ. 
DV disruption is similarly correlated with the manifestation of DNA 
degradation and mitochondrial depolarization (Figures 4.6B and 4.6C 
respectively). Next, the relationship between the PCD-like features and cell 
death was examined. CQ cytocidality is correlated with DNA degradation and 
ΔΨm loss, as seen in Figures 4.7A and 4.7B respectively. Again, reinvasion 
decreased drastically as DNA degradation or mitochondrial depolarization 
increased. 
 
4.3.5 Induction PCD-like features in K1 
K1 is a CQ-resistant strain that also withstands CQ-mediated DV disruption 
(Figure 3.3C). This strain was therefore used to investigate if DNA 
degradation and mitochondrial depolarization could be induced in a CQ-
resistant model. CQ-induced DNA degradation was both concentration- and 
duration- dependent; however, this effect of CQ was substantially reduced in 
K1 (Figure 4.8). In fact, statistically significant results were only consistently 
obtained at 10 h, at concentrations of 2 μM and above. K1, however, was more 
susceptible to mitochondrial depolarization. ΔΨm loss was both concentration- 
and duration-dependent, and near total loss of JC-1 red staining could be 
achieved at a sufficiently high duration of treatment (Figure 4.9). The 
minimum duration of CQ treatment for consistently significant results was 6 h 
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(at ≥ 3 μM), while that for the lowest concentration was 500 nM (at 8 and 10 
h). Therefore, CQ resistance abrogates DNA degradation but only somewhat 
reduces mitochondrial depolarization on CQ treatment. 
 
4.3.6 Cidality of CQ in K1 
A typical continuous-exposure growth inhibition assay performed on K1 
showed that for CQ, the IC50 was approximately 300 nM. In the cytocidality 
assay, the minimum concentration required to inhibit reinvasion at all was 1 
μM, demonstrating the distinction between a cytostatic and cytocidal 
measurement. Interestingly, the cidality of CQ appeared to be dose-
independent beyond 2 μM (Figure 4.10A), with the duration of treatment 
playing a larger role (Figure 4.10B). However, even at the longest duration 
and highest concentration (10 h and 10 μM), reinvasion was reduced by only 
approximately 50%. Although this is far higher than the previously stated 300 
nM concentration required for half the cytostatic potency, it is not 
unprecedented; a previous report has found that another CQ-resistant strain, 
Dd2, has a half-maximal lethal CQ dose (LD50) of about 16 μM with a 6 h 
treatment duration (Paguio et al., 2011).  
 
4.3.7 Correlations in K1 
Although both DNA degradation and mitochondrial depolarization are 
significantly correlated with CQ killing of the parasite in K1 (Figure 4.11), 
several caveats have to be stated. First, despite the marginal degree of DNA 





Figure 4.8 K1 is resistant to CQ-induced DNA degradation. The CQ-resistant 
strain K1 was assessed for DNA degradation after treatment with CQ. (A) 
Concentration-dependence of DNA degradation. (B) Duration-dependence of DNA 
degradation. Total duration for this assay was 10 h. The sub-G1 population was 
determined by gating on the bottom decile of the vehicle control in each duration set. 























































































Figure 4.9 CQ can induce ΔΨm loss in K1 at high durations. (A) Concentration-
dependence of mitochondrial depolarization. (B) Duration-dependence of 
mitochondrial depolarization. Total duration for this assay was 10 h. Data represent 































































































Figure 4.10 Concentration- and time-dependence of cell death in K1. CQ 
cytocidal activity in the CQ-resistant strain K1. (A) Concentration-dependence of CQ 
killing. (B) Duration-dependence of CQ killing. Total duration for this assay was 34 

















































































Figure 4.11 Correlation of PCD-like features to cell death in K1. The 
relationships between cell death and DNA degradation or mitochondrial 
depolarization are presented in panels A or B respectively. Similar to Figure 4.7, the 
x-axis in panel B has been inverted. Spearman’s rank correlation coefficient (ρ) of 
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ρ = -0.695 
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parasite, accounting for the correlation. Second, although ΔΨm loss correlates 
with CQ killing, it is a poor indicator as near total loss did not reflect a similar 
extent of cell death. In other words, mitochondrial depolarization did not result 
in cell death for at least a substantial proportion of the parasites. 
 
4.3.8 Conclusion 
Several key conclusions can be drawn from the data presented in this chapter. 
First and of the largest significance, by combining cytocidal assays and 
measurements of features thought to indicate cell death, it has been 
demonstrated that mitochondrial depolarization as measured by JC-1 
aggregation is not an indicator of cell death. Although readily induced by CQ 
treatment, this phenotype appears to be incidental to cell death, as the CQ-
resistant K1 is able to progress and reinvade after the drug has been washed 
off. Multiple reports have used mitochondrial dysfunction as an indicator of 
PCD in P. falciparum (Table 2.1), without investigating the relevance of this 
phenotype in P. falciparum. That the parasite should not be considered similar 
to mammalian systems cannot be overemphasized. In the blood stage of P. 
falciparum, maintenance of the ΔΨm has only one essential function, which is 
to supply ubiquinone for the folate biosynthesis pathway; acquisition of an 
alternate pathway that dispenses with the need for ubiquinone renders the 
parasite immune to drugs that target mitochondrial electron transport (Painter 
et al., 2007). Furthermore, atovaquone treatment targeting the electron 
transport chain does not kill the parasite but renders it cytostatic (Painter et al., 
2010). Interestingly, even in some mammalian cells, cell death due to 
mitochondrial outer membrane permeabilization may be abrogated by a 
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ubiquitin-mediated degradation of cytochrome c (Gama et al., 2014), belying 
the presumption of cell death upon mitochondrial outer membrane 
permeabilization. How CQ treatment results in the loss of ΔΨm is still 
unknown; speculatively, perhaps CQ being a weak base might act as a proton 
sponge and disrupt the proton gradient without permeabilizing the outer 
mitochondrial membrane. 
 
On the other hand, Fluo-4 redistribution appears to be a good indicator of CQ 
killing in 3D7, corresponding neatly with a decrease in reinvasion (Figure 
4.6A). K1, while CQ-resistant, is still slightly susceptible to CQ-induced Fluo-
4 redistribution at a high CQ concentration (Figure 3.3C). Surprisingly, this 
concentration and duration of CQ treatment did not result in an observable 
decrease in viability (Figure 4.10). An intriguing explanation could be that CQ 
resistance is partially mediated by the ability to recover from DV damage. 
However, this author believes it is more likely that CQ directly interferes with 
Fluo-4 localization. PfMDR1 is a transporter protein situated on the DV 
membrane. CQ is a substrate of this protein, with certain haplotypes resulting 
in increased CQ accumulation in the DV (Sanchez et al., 2011). PfMDR1 also 
transports the dye Fluo-4 into the DV (Rohrbach et al., 2006). Taken together, 
it thus seems likely that high concentrations of CQ may competitively inhibit 
PfMDR1 and result in cytosolic Fluo-4 fluorescence without disrupting the 
DV. 
 
DNA degradation seems to be a better marker for cell death; an increase in the 
proportion of sub-G1 parasites matched the exquisite susceptibility of 3D7 to 
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CQ killing, while in the resistant K1, DNA degradation was minimal. This is 
reasonable as there is likely no way for the parasite to recover from extensive 
DNA damage. 
 
In 3D7, CQ treatment readily resulted in DV disruption at concentrations and 
durations below that in a previously-published report (Ch’ng et al., 2011). In 
fact, given that serum concentrations of CQ are elevated beyond 1 μM for an 
extended period (Mzayek et al., 2007), it is very probable that DV disruption 
plays a significant role in the resolution of CQ-susceptible malaria with CQ 
treatment. Although the canonical mechanism of CQ is to inhibit hemozoin 
formation, this effect is typically tested at low concentrations of CQ not 
representative of clinical circumstances. There is some evidence that at higher 
concentrations that are more medically relevant, differences in CQ 
accumulation alone cannot account for CQ resistance (Cabrera et al., 2009). 
Perhaps DV disruption may contribute more to CQ-mediated killing in 

















In mammalian cells, the final stages of apoptosis involve the clearance of 
apoptotic cells by phagocytes. This is a critical step as post-apoptosis 
secondary cell lysis results in damaging inflammatory responses that could 
lead to long-term autoimmune diseases (Rosen and Casciola-Rosen, 1999). 
One of the key processes in the clearance of apoptotic bodies is the 
presentation of “eat me” signals on the surface of the dying cell, which are 
molecules that trigger the recognition and engulfment of the cell by a 
phagocyte. Of these, the best known is PS. PS is restricted to the inner leaflet 
of the plasma membrane bilayer through the activity of flippase, an 
aminophospholipid translocase. Apoptosis triggers an influx of Ca2+ and 
activates scramblase, resulting in the distribution of PS to the outer leaflet and 
exposing it to phagocytes (Segawa et al., 2014; Williamson and Schlegel, 
2002). Other “eat me” signals proposed include changes in glycosylation 
patterns, exposure of calreticulin, and ICAM-3; however, these have only been 
weakly characterized (Lauber et al., 2004; Segawa and Nagata, 2015). Using a 
surrogate model in which ligands are bound to erythrocyte surfaces, Hoffmann 
et al. (2001) showed that PS presentation alone is not sufficient to induce 
engulfment. Instead, other “eat me” signals attach the cell to the phagocyte, 
and PS then induces phagocytosis. This has been described as “tethering and 
tickling”, as other ligands tether the dying cell to the phagocyte before PS 
“tickles” and triggers engulfment (Somersan and Bhardwaj, 2001). 
 
This chapter investigates whether the induction of a PCD-like phenotype 
results in phagocytic clearance. Late-stage parasites decrease the deformability 
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of the host cell and render themselves susceptible to splenic filtration and 
clearance. This is avoided by the sequestration of the late-stage parasites in the 
small vessels and thus removing these parasites from peripheral circulation 
(Buffet et al., 2011; Cranston et al., 1984; Herricks et al., 2009). Therefore, the 
phagocytes that these late-stage parasites encounter are typically the 
circulating monocytes and neutrophils. Here, a THP-1 monocyte cell line is 














5.2 Methods and materials 
3D7 parasites were cultured and synchronized as in Sections 3.2.1 and 3.2.2. 
 
5.2.1 Phosphatidylserine exposure 
Trophozoite-stage parasites at 10% parasitemia and 1.25% hematocrit were 
treated with 1 μM of each compound in a 96-well flat-bottomed plate. 
Following this, the cells were stained with 1 μg/ml of Hoechst 33342 and 
1:100 annexin V-FITC (BioVision) in binding buffer as per the manufacturer’s 
instructions. For autofluorescence controls, annexin V-FITC was omitted from 
the staining step. Cells were then loaded on the CyAn ADP flow cytometer, 
excited by 405 nm and 488 nm lasers, and analysed on the blue and green 
channels. 
 
5.2.3 Culture of THP-1 cells 
The monocytic cell line THP-1 was cultured in THP-1 culture medium (TCM) 
comprising RPMI 1640 supplemented with 2.2 g/l sodium bicarbonate, 0.03% 
(w/v) L-glutamate, 100 U/ml penicillin, 100 μg/ml streptomycin, and 10% 
heat-inactivated fetal bovine serum. Culture was maintained in vented 25 cm2 
or 75 cm2 cell culture flasks at 37 °C and 5% CO2. Cells were passaged before 
a density of 106 cells/ml was surpassed; cell density was determined by counts 
on a haemocytometer. Trypan blue staining was used to assess viability of 
cells prior to each experiment, requiring at least 95% viability for each 




5.2.3 Drug-induced dihydroethidium uptake 
Mid-trophozoite parasites (15% parasitemia, 5×107 erythrocytes/ml) were pre-
incubated with either a calcium chelator (BAPTA-AM, BAPTA sodium salt or 
EGTA) or vehicle control in MCM for 30 min at 37 °C. 1 ml of pretreated 
parasite culture was then added to test compounds in a 24-well plate to a final 
concentration of 1 μM of each drug. Parasites were then incubated in culture 
conditions for 4 h, after which they were stained with 5 μg/ml 
dihydroethidium (DHE) in PBS for 20 min at 37 °C. Cells were then washed 
twice with 1 ml prewarmed TCM, then resuspended in 1 ml TCM with 
2.5×105 THP-1 cells per well. The culture plate was then incubated in a CO2 
incubator for a further 4 h to allow for phagocytosis. Next, erythrocytes were 
lysed by resuspending cells in 1 ml lysis buffer (1.7 mM Tris, 0.14 M 
ammonium chloride, pH 7.4) for 8 min at 37 °C. Cells were then washed and 
resuspended in PBS for analysis by flow cytometry with the CyAn ADP flow 
cytometer. 
 
5.2.4 Assessment of phagocytosis by Giemsa smear 
Parasites were treated with the compounds and coincubated with THP-1 as in 
Section 5.2.3, but were not stained with DHE. Two additional controls were 
included: (1) for the parasite treatment, one sample was placed on ice to 
inhibit growth of the parasite; (2) during coincubation with THP-1, a replicate 
plate was incubated at 4 °C instead to inhibit phagocytosis. After lysis of 
unphagocytosed cells, the remaining THP-1 cells were resuspended in PBS 
supplemented with 1% bovine serum albumin (BSA) and thin smears were 
 91 
 
made on glass slides. Cells were then fixed with methanol and stained with 
Giemsa. THP-1 cells were then counted by a blinded technician. 
 
5.2.5 Statistical analyses 
Statistical analyses were performed in Microsoft Excel 2013 (t-tests) or 









5.3.1 Annexin V staining of parasites 
Cells were stained with Hoechst 33342 to distinguish between pRBCs and 
uRBCs, and with FITC-conjugated annexin V to assess PS presentation. In 
mammalian cells, a typical control for membrane integrity is to utilize the 
membrane-impermeant nucleic acid stain propidium iodide. This is to exclude 
the possibility that the observed annexin V staining is a result of binding to the 
inner leaflet of the plasma membrane. However, as the pRBC has two 
additional membranes surrounding the nucleus (the parasitophorous vacuole 
membrane and the parasite plasma membrane), the absence of PI staining may 
not indicate an intact RBC plasma membrane. Furthermore, some PI staining, 
albeit slight, in Plasmodium-infected cells can occur without a 
permeabilization step (Jang et al., 2014). Similarly, ethidium bromide 
exclusion is a marker for membrane integrity in a similar manner to PI 
(Aeschbacher et al., 1986; Dive et al., 1990). Trophozoite-stage P. falciparum 
can be stained with ethidium bromide (Chan et al., 2012; Gallo et al., 2012; 
Tippett et al., 2007), suggesting membrane perforation as the parasite matures. 
As such, PS externalization was assessed without a control for membrane 
integrity similar to previously-published reports (Engelbrecht and Coetzer, 
2013, 2015; Pattanapanyasat et al., 2010), keeping this caveat in mind. Here, 
MQ and QC were used as non-DV disrupting controls (Figure 3.2A) that could 
kill the parasite. Thapsigargin (TSG) is an inhibitor of sarco/endoplasmic 
reticulum Ca2+ ATPase (SERCA) that is able to cause Ca2+ dysfunction in the 
parasite by causing the endoplasmic reticulum to release its Ca2+ payload 
while also resulting in Ca2+ loss from the DV (Alves et al., 2011; Biagini et 
 93 
 
al., 2003; Eckstein-Ludwig et al., 2003). At the concentration used (1 μM), 
TSG was not lethal to the parasite (data not shown; see also Eckstein-Ludwig 
et al. (2003)). TSG was thus included as a control for Ca2+ flux-mediated 
effects. FITC fluorescence of the parasites is normalized to the PBS (vehicle) 
control and presented in Figure 5.1. As noted previously, pRBCs treated with 
QC exhibit some fluorescence in the green channel even without incubation 
with annexin V-FITC (Figure 5.1B). Correcting for this drug-induced 
autofluorescence, only TSG showed a significant increase in annexin V 
staining (Figure 5.1C). However, looking also at the uRBCs within the same 
sample, it can be seen that the parasitized cells exhibit PS inversion even 
without drug treatment (Figure 5.2). This is consistent with previous reports 
indicating that parasite infection causes PS externalization (Eda and Sherman, 
2002; Lang et al., 2004a; Pattanapanyasat et al., 2010; Schwartz et al., 1987). 
The effect of TSG disappears if annexin V staining of uRBCs was accounted 
for, indicating that the effect of TSG was not specific to pRBCs. As no further 
increase in annexin V staining was observed even on drug treatment, the 
absence of a control for membrane integrity is moot.  
 
5.3.2 Drug-induced DHE uptake 
Although drug treatment did not induce any apparent increase in PS 
externalization, presentation of other “eat me” signals might be induced 
through drug treatment. To assess if phagocytosis would be increased by DV 
disruption, a THP-1 monocyte model was used. A previous report described 
the use of DHE as a marker for phagocytosis (Chan et al., 2012), and that 




Figure 5.1 DV disruption does not induce further phosphatidylserine 
presentation. Parasite cultures were treated with 1 μM of the compounds indicated or 
PBS control for 4 h, then stained with Hoechst 33342 and annexin V-FITC and 
analysed by flow cytometry. Parasites were selected by gating on Hoechst-positive 
events. Fluorescence intensity was normalized to the PBS control. (A) Annexin V-
FITC staining of parasites. (B) Autofluorescence of parasites without annexin V 
staining after drug treatment. (C) Autofluorescence-subtracted fluorescence with 
annexin V-FITC staining. Only TSG was significantly different from the PBS control 





























































































Figure 5.2 PRBCs exhibit increased annexin V staining regardless of treatment. 
Infected RBCs display increased staining regardless of drug treatment. (A) 
Representative histogram of annexin V-FITC staining for pRBCs and uRBCs within 
the same sample. Red, uRBC; blue, pRBC. (B) Intensity of pRBC FITC fluorescence 
































were treated with the test compounds prior to staining with DHE and 
coincubation with THP-1 cells. After lysis of unphagocytosed erythrocytes, 
the THP-1 cells were assessed for DHE fluorescence by flow cytometry. 
Figure 5.3A shows representative histograms of THP-1 fluorescence after 
coincubation with parasites treated with the indicated drugs. As presented in 
Figure 5.3B, coincubation with CQ-, QC-, DCB-, or TSG-treated parasites led 
to increased DHE staining (red points). QN treatment did not result in a 
significant difference from the vehicle control. DHE fluorescence from MQ-
treated parasites were significantly different from the vehicle control, but the 
effect size was small and could have simply been statistical noise. It is 
therefore demonstrated here that the DV-disrupting compounds CQ, QC and 
DCB were able to induce increased DHE uptake.  
 
5.3.3 Role of Ca2+ in drug-induced DHE uptake 
Given that TSG could also exert a similar effect, the relevance of Ca2+ was 
examined with calcium chelators. The DV is a Ca2+ store, and damage 
inflicted on this organelle could result in downstream Ca2+-mediated events 
such as the activation of the host erythrocyte’s cell death pathway (Alves et 
al., 2011; Biagini et al., 2003; Garcia, 1999; Lang et al., 2004a). Incubation 
with the intracellular Ca2+ chelator BAPTA-AM prior to drug treatment was 
able to abrogate DHE uptake induced by the DV disruptors CQ, QC, and DCB 
but not by TSG (Figure 5.3B, blue points). Pretreatment with the membrane-
impermeant chelators BAPTA sodium salt and EGTA, however, were not able 
to replicate this effect (Figure 5.4), indicating that CQ, QC, and DCB effects 
could be attributed to intracellular Ca2+ activity. 
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5.3.4 Phagocytosis assessed by Giemsa smears 
One surprising finding was the shape of the DHE fluorescence histograms 
obtained (Figure 5.3A). Given the low likelihood that all THP-1 monocytes 
would have ingested at least one parasite, we would have expected to see at 
least two distinct populations from the histogram: monocytes that have 
ingested at least one parasite, and monocytes that have not engulfed any 
parasites. Instead, the entire population of THP-1 cells appeared to exhibit 
increased DHE staining. Preincubation of the monocytes with cytochalasin D, 
an inhibitor of actin polymerization and thus phagocytosis, was able to 
suppress DHE uptake while unstained parasites did not induce 
autofluorescence (data not shown). Instead, it was found that the supernatant 
of DHE-stained cells was able to impart DHE staining to the THP-1 cells 
(Figure S5.1). Giemsa smears were thus performed to assess the extent of 
phagocytosis after drug treatment. In this assay, THP-1 cells were spread on a 
glass slide and assessed by light microscopy to identify cells that have 
engulfed at least one parasite, by looking for the presence of hemozoin in 
these cells (Figure 5.5). An additional control was included by placing the 
parasite culture on ice (denoted as “Cold”) instead of treating with drugs or the 
PBS (vehicle) control; this was to inhibit parasite growth to account for stage-
dependent effects. Here, drug treatment was unable to induce enhanced 
phagocytosis by the monocytes (Figure 5.5A). As a control for incomplete 
lysis of unphagocytosed parasites, the coincubation step was performed at 
4 °C to inhibit phagocytosis (Figure 5.5B); phagocytosis was abolished, 








Figure 5.3 DV disruption increases DHE uptake in a Ca2+-dependent manner. 
THP-1 was analysed for DHE uptake by flow cytometry as a proxy for phagocytosis. 
(A) Representative histograms of THP-1 coincubated with parasites treated with PBS, 
CQ, or DCB. (B) Median fluorescence intensity of THP-1 after coincubation with 
parasites, expressed as the difference from the PBS control (shown as 0). * indicates 
significant difference from the PBS control in the no-pretreatment (Veh) group. *, p < 
0.05; **, p < 0.01; ***, p < 0.001. § indicates significant difference between the no-


















Figure 5.4 Extracellular Ca2+ does not contribute to DHE uptake. Panels A and B 
show the effect on DHE uptake of extracellular Ca2+ chelators BAPTA sodium salt 
and EGTA respectively, compared to the no-pretreatment group (Veh). No pair was 
significantly different with the sign test (n = 6). Note that the no-pretreatment group 











Figure 5.5 DHE uptake is not attributable to phagocytosis. THP-1 cells were 
spread on glass slides and stained with Giemsa. The number of cells with at least one 
visible hemozoin crystal was enumerated by a blinded technician on a light 
microscope. (A) THP-1 after coincubation with parasites in a 37 °C CO2 incubator. 
(B) THP-1 after coincubation with parasites at 4 °C, to serve as a control for 
incomplete lysis of unphagocytosed RBCs. No parasite treatment resulted in a 
significant difference with the PBS-treated or cold-treated controls with the Student’s 


















































































This chapter demonstrates that unlike mammalian apoptosis, the induction of 
DV damage and subsequent cell death could not enhance phagocytosis. 
However, the observed Ca2+-dependent increase in DHE uptake has to be 
addressed. DHE is a membrane-permeable compound that can be oxidized 
intracellularly to ethidium, which binds to nucleic acids and fluoresces in the 
orange spectrum. DV permeabilization induces DNA damage via a BAPTA-
AM-inhibitable mechanism (Ch’ng et al., 2011). In the cells treated with CQ, 
QC, and DCB, downstream DNA degradation could have resulted in the 
release of ethidium into the supernatant. As ethidium is not membrane 
permeable, the THP-1 monocytes could have taken up the dye through 
macropinocytosis; this is a process that is inhibitable by cytochalasin D (Dutta 
and Donaldson, 2012). Pretreatment with BAPTA-AM prior to drug 
incubation would therefore also reduce the amount of ethidium released into 
the supernatant, causing the observed suppression of DHE uptake. Although 
several reports have utilized fluorescent dyes in phagocytosis assays (Chan et 
al., 2012; Gallo et al., 2012; Tippett et al., 2007), caution is necessary when 
assessing drug-induced phagocytosis with such assays. The use of cytosolic 
GFP-expressing parasites in a similar experiment was also attempted, but DV 
rupture suppressed parasite fluorescence (data not shown); this could be due to 
degradation by proteases released from the DV. A similar effect was observed 
with dyes that bind to cytosolic proteins such as carboxyfluorescein 




Although no significant differences could be detected on the Giemsa smears, 
in parasites treated with DV disruptors the hemozoin crystals appeared smaller 
(personal observation; data not shown). This was not surprising as DV damage 
would likely inhibit hemozoin formation. Furthermore, CQ and QC are 
predicted to inhibit hemozoin formation. This effect on hemozoin may bias the 
assay against drugs that target the DV, as smaller hemozoin crystals are less 
likely to be noticed in the Giemsa smears. Interestingly, there is some 
evidence that high dose CQ treatment can decrease phagocytosis through an 
unknown mechanism (Shalmiev et al., 1996). 
 
It should also be noted that the role phagocytosis plays in protection against 
malaria is still controversial. Multiple reports have established that 
phagocytosis of hemozoin, isolated DVs, or parasitized erythrocytes causes 
immunosuppression (Dasari et al., 2011; Ihekwereme et al., 2014; Leitner and 
Krzych, 1997; Schwarzer et al., 1998, 2003; Skorokhod et al., 2004), leaving 
the patient more susceptible to secondary infections. Enhancement of 






















In mammalian nucleated cells, apoptosis is well-characterized and is 
transcriptionally regulated (Dudgeon et al., 2009). Mature erythrocytes, 
lacking nuclei, cannot influence cell death through gene expression. The 
mitochondrion, another organelle central to the intrinsic apoptotic pathway, is 
also absent. However, despite these dissimilarities, erythrocyte PCD or 
eryptosis has been reported widely and is fairly well-established (Bratosin et 
al., 2001; Daugas et al., 2001; Lang and Lang, 2015; Lang et al., 2003; Vittori 
et al., 2012; Wieder et al., 2005). Inducers of eryptosis include oxidative stress 
or an increase of intracellular Ca2+ activity. Oxidatively-stressed RBCs trigger 
a pathway similar to that of the extrinsic apoptotic pathway, culminating in the 
activation of caspase 3 and 8 and the externalization of PS without the 
involvement of calpain (Mandal et al., 2005). On the other hand, inducing 
Ca2+ influx with ionomycin, a calcium ionophore, resulted in a calpain-
mediated form of cell death that does not involve caspase activity (Berg et al., 
2001). Ceramide enhances the potency of Ca2+ in inducing this form of 
eryptosis (Lang et al., 2004b). In human erythrocytes, only μ-calpain is 
present, which is activated by micromolar concentrations of Ca2+ (Murachi et 
al., 1981). Activation of this calpain in the RBC results in degradation of the 
erythrocyte cytoskeleton. The cysteine protease μ-calpain undergoes a 
conformational change upon binding Ca2+ and thus aligns its active site 
(Moldoveanu et al., 2002). Another Ca2+-activated enzyme, tissue 
transglutaminase, crosslinks membrane cytoskeletal proteins and decreases 
RBC deformability while also facilitating the activation of μ-calpain by 
crosslinking the μ-calpain small and large subunits (Sarang et al., 2007; Smith 
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et al., 1981). The erythrocyte cytoskeletal proteins spectrin, ankyrin, and 
protein 4.1 are known degradation targets of μ-calpain (Boivin et al., 1990). 
 
As discussed previously, parasite invasion of an erythrocyte renders the 
erythrocyte permissive to Ca2+ influx, but Ca2+ levels in the RBC cytosol 
remain suppressed due to sequestration in various parasite compartments such 
as the DV, endoplasmic reticulum, parasitophorous vacuole, and 
mitochondrion (Adovelande et al., 1993; Alleva and Kirk, 2001; Biagini et al., 
2003; Gazarini and Garcia, 2004; Gazarini et al., 2003; Rohrbach et al., 2005). 
DV rupture would therefore interfere with one of the few calcium stores of the 
parasite, while possibly also disrupting the mitochondrion and causing further 
Ca2+ release. It is therefore conceivable that DV disruption can activate μ-
calpain. Supporting this, P. falciparum can hijack host μ-calpain to aid in its 
exiting from the host cell; depletion of μ-calpain blocks this egress. 
Furthermore, despite the acidic nature of the DV, several DV proteases have 
been implicated in degradation of the host cytoskeleton. Plasmepsin II, a 
hemoglobinase, has demonstrated activity against spectrin and protein 4.1 at 
near-neutral pH (Bonniec et al., 1999). More recently reported, another 
hemoglobinase, falcipain 2 (FP-2), cleaves protein 4.1 and ankyrin at cytosolic 
pH during the latest stages of the erythrocytic cycle, facilitating parasite egress 
from the host RBC (Hanspal et al., 2002). This egress can be blocked by 
inhibiting FP-2 with ankyrin peptides (Dhawan et al., 2003), demonstrating 
the essential nature of this interaction. Knobs are also associated with spectrin 
remodelling and are localized to spectrin-rich regions (Shi et al., 2013). Taken 
together, DV rupture may result in the release of sequestered calcium, 
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cytoskeletal-degrading enzymes and the subsequent breakdown of the host 
RBC cytoskeleton.  
 
Cytoskeletal modifications also play an important role in the pathogenesis of 
P. falciparum malaria. Infected erythrocytes present protrusions on their 
surface as the parasites grow; these knobs sequester the parasites from 
peripheral circulation, and can mediate disease as discussed in Section 2.2.3. 
A major parasite cytoadhesion factor, erythrocyte membrane protein 1 
(PfEMP1), is a transmembrane protein that clusters at these knobs. Another 
parasite-expressed protein, knob-associated histidine-rich protein (KAHRP), is 
a major component of the knobs and knockout mutants of KAHRP are 
knobless and exhibit impaired cytoadherence (Crabb et al., 1997). KAHRP sits 
under the surface of the host plasma membrane and interacts with the 
intracellular domain of PfEMP1 dynamically, tethering PfEMP1 to the knobs 
(Ganguly et al., 2015). KAHRP in turn interacts with the membrane binding 
domain of ankyrin (Weng et al., 2014), an adaptor protein associated with the 
spectrin-based cytoskeleton. Given the likelihood that DV rupture induces 
cytoskeletal disassembly, this chapter investigates the effect DV disruption has 









6.2 Methods and materials 
3D7 parasites were cultured and synchronized as in Sections 3.2.1 and 3.2.2. 
 
6.2.1 Selection for knob-positive parasites 
Parasites expressing knobs on the erythrocyte membrane were enriched as 
previously published (Moll, 2013). Briefly, trophozoite-stage parasites were 
washed once in RPMI 1640 then resuspended in a 15 ml centrifuge tube with 4 
ml RPMI medium supplemented with 0.7% (wt/v) gelatin from porcine skin. 
This suspension was incubated at 37 °C for 1 h, taking care to avoid agitation. 
The supernatant containing the knob-positive parasites was then carefully 
transferred to a clean tube, taking care not to perturb the sedimented cells. The 
knob-positive parasites were then pelleted by centrifugation, washed once with 
RPMI 1640, then returned to culture in MCM with fresh erythrocytes added to 
1.25% hematocrit.  
 
6.2.2 Drug treatment of parasites 
Early-mid trophozoite stage parasites at 10% parasitemia, 1.25% hematocrit 
were incubated with CQ, QC, DCB, MQ, or QN at 1 μM for 10 h in a 96-well 
flat-bottomed plate. Where indicated, a control sample was placed on ice to 
inhibit growth of the parasite. Pretreatment of parasites with a Ca2+ chelator or 
protease inhibitors was performed by incubating the cultures at 37 °C for 30 
min with BAPTA-AM (50 μM), E64-d (20 μM), ALLN (10 μM), z-
VAD(Ome)-fmk (20 μM), or AEBSF (100 μM). Parasite cultures were then 
treated with the drugs without any prior washing. The plate was contained in a 
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hypoxic chamber flushed with culture mixture gas and incubated in the dark at 
37 °C. 
 
6.2.3 Anti-KAHRP immunofluorescent staining 
Treated parasites from the previous section was washed once with 200 μl PBS. 
The cells were then fixed by resuspending in 4% (wt/v) paraformaldehyde 
(PFA) and 0.0075% (v/v) glutaraldehyde in PBS and incubating at room 
temperature for 30 min. Cells were then washed in PBS and permeabilized by 
incubation in 0.1% (v/v) Triton X-100 in PBS for 5 min at room temperature. 
The cells was then washed again in PBS, after which they were resuspended in 
200 μl of 0.1 M glycine in PBS for 30 min at room temperature to quench 
unreacted aldehyde. They were then resuspended in 3% BSA in PBS and 
stored at 4 °C overnight for blocking. The next day, the cells were incubated 
with anti-KAHRP monoclonal mouse IgG antibody (European Malaria 
Reagent Repository; clone 18.2) at 5 μg/ml in 3% BSA for ≥ 1 h. This was 
followed by washing thrice in PBS, then staining with a 1:500 dilution of goat 
anti-mouse IgG FITC-conjugated polyclonal antibody (Abcam) in 3% BSA, 
supplemented with 1 μg/ml Hoechst 33342, for ≥ 1 h. Single-stain controls 
were obtained by omitting Hoechst or the FITC-conjugated antibody at this 
step. Cells were then washed thrice and resuspended in PBS for analysis. 
 
6.2.4 ImageStream analysis of treated cells 
Cells were loaded onto the ImageStreamX Mark II and acquired as in Section 
4.2.1. Analysis was performed on the companion software IDEAS (version 
6.1) and is summarized in Figure 6.1. Similar to Section 4.2.1, cells were 
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gated for focus. However, whether cells were facing orthogonally to the 
imaging plane was deemed irrelevant for the analysis of KAHRP loss; events 
were only gated for singlet cells. The events were subject to other analyses, 
one of which was to examine the shape of the erythrocytes; for KAHRP-
positive cells, the proportion of round cells was determined with the 
Circularity function in IDEAS (representative images in Figure S6.1). 
 
6.2.5 Atomic force microscopy 
Early-mid trophozoite parasites at 10% parasitemia were treated with 1 μM of 
DCB for 6 h, then washed twice in PBS. Cells were resuspended in 1% BSA 
in PBS and spread thinly on glass grid slides. The slides were then air-dried at 
45 °C for 1 h and stored in a dehumidified chamber until examination. Atomic 
force microscopy (AFM) was performed with the Dimension FastScan 
microscope with Bruker AFM probes (FastScan-B). Height images were 
captured at 512 samples per line, with a scan rate of 3 to 4 Hz. Analysis of the 
images was performed with the NanoScope Analysis software (version 1.40). 
 
6.2.6 Culturing of CHO cells 
Chinese hamster ovary cells expressing human ICAM-1 (CHO-I) were a kind 
gift from Dr Laurent Rénia. These cells were cultured in CHO culture medium 
(CCM) consisting of F-12 (Ham) medium (Gibco) supplemented with 10% 
heat-inactivated fetal bovine serum, 100 U/ml penicillin, and 100 μg/ml 
streptomycin. Cells were cultured in vented 25 cm2 or 75 cm2 cell culture 











Figure 6.1 Representative plots for KAHRP cytometry. Parasites were acquired as 
Hoechst-positive events. Acquired events then were gated for acceptable focus, 
followed by singlet cells in the bright field channel. Events were then plotted as 




Time 0 DCB 
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seeding into a fresh flask when the monolayer was approximately 70% 
confluent. 
 
6.2.7 Panning for cytoadherent parasites 
Cultures enriched for knob-positive trophozoite-stage parasites were washed 
twice in cytoadhesion buffer (CB) consisting of RPMI with HEPES and 
without bicarbonate, supplemented with 0.5% (wt/v) Albumax II (Life 
Technologies) and adjusted to pH 6.8. Parasites were then resuspended in CB 
to 3% hematocrit. The CHO-I monolayer in the culture flask was gently 
washed once with CB, then the parasite culture was overlaid on the 
monolayer. The flask was then incubated at 37 °C without CO2 for 1 h, with 
gentle rocking every 15 min to resuspend settled cells. Next, unattached cells 
were aspirated and discarded, and the monolayer gently washed thrice with 
CB. On the final wash, the CHO-I monolayer was inspected for cytoadherent 
RBCs by light microscopy; cytoadherence was observed to increase over 
multiple pannings. The CHO-I monolayer was then overlaid with MCM 
supplemented with fresh RBCs to 1.25% hematocrit, placed in a hypoxic 
chamber flushed with parasite culture mixture gas, and incubated at 37 °C for 
24 h to allow for reinvasion. MCM contained ring-stage parasites was then 
transferred to a fresh flask and culture was resumed as in Section 3.2.1. 
Parasites were selected on CHO-I regularly to maintain cytoadherence. 
 
6.2.8 Cytoadhesion assay 
CHO-I cells were seeded in Lab-Tek II 8-well chambered glass slides (Nunc) 
at 2 × 104 cells in 400 μl and cultured until confluent. Cells were inspected 
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daily by light microscopy and slides were rocked to redistribute cells if 
necessary. When confluent, CHO-I cells were fixed by incubation in 4% PFA 
in PBS for 15 min at room temperature, then washed twice in PBS and stored 
in 5% BSA at 4 °C until used. Where indicated, the CHO-I monolayer was 
incubated with 10 μg/ml anti-ICAM-1 monoclonal antibody (Bio-Rad; clone 
15.2) in 5% BSA for ≥ 1 h prior to the cytoadhesion assay. Immediately before 
use, monolayers were washed once with 200 μl CB. Early-mid trophozoite 
stage 3D7 parasites were treated at 10% parasitemia, 1.25% hematocrit at a 
volume of 200 μl with the conditions stated in Section 6.2.2, then washed 
twice with 200 μl of CB. Parasites were then resuspended in 200 μl CB and 
overlaid on the CHO-I monolayers in the chamber slide. One well was used 
for uRBCs at the same hematocrit as a control for complete washing. The 
chamber slide was then incubated for 1 h at 37 °C without CO2, with gentle 
rocking every 15 min to resuspend sedimented cells. At the end of the 
incubation, non-adherent cells were aspirated off and the chamber removed. 
The slide was promptly transferred to a Petri dish of CB to prevent drying out. 
Washing of the slide was performed thrice, by gently rocking the Petri dish 
and replacing the CB after each wash. On the third wash, the slide was 
inspected for any uRBCs still attached to the monolayer; three washes were 
sufficient for all assays performed. Next, the Petri dish was filled with 1% 
glutaraldehyde in PBS, sealed with parafilm, and stored at 4 °C overnight to 
fix the cells. Slides were then carefully rinsed once with water and stained 
with 1% Giemsa solution for 20 to 30 min. Next, the slides were again rinsed 
with water to remove residual Giemsa solution and air-dried at 45 °C. Using 
three randomly-selected fields for each sample, RBCs attached to the 
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monolayer were then enumerated by light microscopy under the 40× objective 
and presented as the mean number of cells per mm2.  
 
6.2.9 Statistical analyses 
Statistical analyses were performed in Microsoft Excel 2013 (t-tests), 
Graphpad Prism 5 (Mann-Whitney U), and SPSS 21 (Wilcoxon signed-rank 





6.3.1 KAHRP loss and altered morphology 
Parasites were treated with DV disruptors (CQ, QC, and DCB) or non-DV 
disrupting antimalarial drugs (MQ and QN) prior to staining for KAHRP. 
Imaging flow cytometry was performed to detect any redistribution of 
KAHRP from the periphery of the cells, with an expected result similar to that 
of interrupted association with ankyrin (Weng et al., 2014). Instead, the depth 
of field of the ImageStream system was too large to assess the localization of 
KAHRP, given the minuscule size of the erythrocytes — untreated pRBCs 
showed fluorescence throughout the cell image and not only at the perimeter 
of the cell. Unexpectedly, DV rupture resulted in a loss of KAHRP signal 
instead, while the non-DV disrupting compounds MQ and QN did not give 
rise to the same effect (Figures 6.1 and 6.2A). Analysis of the bright field 
images also showed that for the subpopulation of cells that remained KAHRP-
positive after DV disruption, cell morphology was rounder than KAHRP-
positive untreated cells (Figure 6.2B). One explanation could be that the DV 
disruptors CQ, QC, and DCB caused these cells to increase in sphericity, 
perhaps due to undigested hemoglobin and therefore increased osmotic 
pressure (Lew et al., 2003). As the cytoskeletal structure is responsible for the 
discoid shape of the erythrocyte (Diez-Silva et al., 2010), cytoskeletal 
degradation may also result in the loss of the biconcave shape and thus an 
increase in sphericity. However, in cells that have lost KAHRP, no differences 
in shape was observed (data not shown). Another possibility could be that a 
certain proportion of pRBCs were already more spherical to begin with, and 





Figure 6.2 DV disruption results in loss of KAHRP and changes in morphology. 
(A) Proportion of KAHRP-positive pRBCs as assessed by anti-KAHRP staining. (B) 
Proportion of the remaining KAHRP-positive cells deemed non-circular, using the 
Circularity function on the bright field. *, p < 0.05; **, p < 0.01; ***, p < 0.005; 
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6.3.2 Involvement of calcium in KAHRP loss 
As the release of Ca2+ was hypothesized to lead to the activation of host 
erythrocyte μ-calpain, the role of Ca2+ in KAHRP loss was investigated. 
BAPTA-AM, an intracellular Ca2+ chelator, was applied to the parasite 
cultures prior to treatment with the compounds. As predicted, chelation of 
intracellular Ca2+ resulted in the total abolishment of KAHRP loss (Figure 
6.3A). However, the increased sphericity of the KAHRP-positive 
subpopulation was not reversed (Figure 6.3B), indicating that another 
mechanism may be involved here. 
 
6.3.3 Effect of protease inhibitors 
Although Ca2+ is a trigger for KAHRP loss, increased cytosolic Ca2+ by itself 
cannot result in the degradation of KAHRP. Hence, a panel of protease 
inhibitors was used to ascertain the class of protease responsible. Four 
protease inhibitors were investigated, namely E64-d, a membrane-permeable 
broadly-acting cysteine protease inhibitor; acetyl-leu-leu-norleucine (ALLN), 
an inhibitor of μ-calpain; z-VAD(Ome)-fmk, a pancaspase inhibitor; and 4-(2-
Aminoethyl) benzenesulfonyl fluoride (AEBSF), a serine protease inhibitor. 
Of these, only the cysteine protease inhibitors E64-d and ALLN were able to 
totally abrogate KAHRP loss (Figure 6.4). The pancaspase inhibitor z-
VAD(Ome)-fmk was included to examine if a similar pathway could be 
responsible for the PCD-like phenotype associated with DV permeabilization; 
DNA degradation was inhibited by application of z-VAD (Ch’ng et al., 2010). 
This inhibitor was found to partially rescue this phenotype induced by QC 





Figure 6.3 Intracellular Ca2+ mediates KAHRP loss. Parasites were pretreated with 
the intracellular Ca2+ chelator BAPTA-AM prior to incubation with the test 
compounds. No-pretreatment data from Figure 6.2 are presented here for comparison. 
(A) Proportion of pRBCs positive for KAHRP. (B) Proportion of the KAHRP-cells 




























































































Figure 6.4 A μ-calpain inhibitor abrogates KAHRP loss. Parasites were pretreated 
with (A) the broad cysteine protease inhibitor E64-d or (B) the μ-calpain inhibitor 
ALLN prior to incubation with the test compounds. No-pretreatment data from Figure 
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Figure 6.5 Z-VAD and AEBSF cannot fully rescue KAHRP loss. Parasites were 
pretreated with (A) the membrane-permeable pancaspase inhibitor z-VAD(Ome)-fmk 
or (B) the serine protease inhibitor AEBSF prior to incubation with the test 
compounds. No-pretreatment data from Figure 6.2 are presented here for comparison. 



















































































chloromethyl ketone caspase inhibitors that is present even at typical 
concentrations (Schotte et al., 1999). The DV is the site of hemozoin 
formation and the disruption of the DV could lead to oxidative damage from 
free heme. Erythrocyte membrane proteins that are oxidized have been 
reported to be degraded by membrane-bound serine proteases (Beppu et al., 
1994; Fujino et al., 1998), and the loss of KAHRP may conceivably be due to 
oxidative damage arising from DV disruption followed by the subsequent 
serine protease proteolysis. Hence, the effect of AEBSF was investigated. 
AEBSF pretreatment did not influence KAHRP loss (Figure 6.5B). The effect 
of these inhibitors on drug-induced increase in sphericity is presented in 
Figures S6.2 and S6.3; data were inconsistent and may not be particularly 
meaningful. 
 
6.3.4 Morphology of knobs upon DV disruption 
Whether KAHRP loss affected the knobs post-knob formation is unknown; 
previous studies have only elucidated the effects of preventing KAHRP 
incorporation in the first place, instead of the effect of KAHRP degradation on 
pre-formed knobs. Here, the parasite knobs were visualized via AFM either 
with or without DCB treatment. Figure 6.6A shows representative 
micrographs of these two samples, with the inset showing Giemsa staining of 
the same cells to ascertain similar parasite stages. Drug-treated parasites were 
generally more condensed than untreated parasites. Interestingly, DCB-treated 
pRBCs had larger knobs, although the density of knobs remained unchanged 
(Figures 6.6B and 6.6C respectively). Clearly, DCB treatment resulted in 










Figure 6.6 DCB treatment results in morphologically altered knobs. (A) 
Representative atomic force micrographs of pRBCs before treatment (Time 0) and 
after DCB treatment. Inset: corresponding Giemsa stains of the depicted cell. (B) Size 
of knobs before and after DCB treatment. (C) Density of knobs before and after DCB 
treatment. ***, p < 0.001; Mann-Whitney U test. 
A 
C B 
Time 0 DCB 
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6.3.5 Effect of DV disruption on cytoadherence 
Parasites were treated in the trophozoite stage, at which point substantial 
amounts of PfEMP1 would have already been inserted into the RBC 
membrane. Although the parasite knobs were morphologically altered, 
whether this has any effect on cytoadhesion is not known. Here, parasite 
cytoadherence was investigated. Parasites selected for ICAM-1 binding were 
treated with DV disruptors or the non-disruptor MQ before overlaying on 
CHO cells expressing ICAM-1. For the negative control, parasite cultures 
were placed at 4 °C to inhibit growth. Antibodies against ICAM-1 was applied 
to the CHO monolayer prior to the cytoadhesion assay as a positive control for 
the loss of cytoadherence; representative images can be seen in Figure 6.7. As 
expected, treatment with CQ, QC and DCB resulted in a loss of 
cytoadherence, while MQ treatment did not decrease adhesion significantly 
(Figure 6.8). No statistical difference was detected between the three DV 
disruptors and the anti-ICAM-1 control (Kruskal-Wallis test).  
 
6.3.6 Conclusion 
The permeabilization of the DV by the three DV disruptors results in the loss 
of KAHRP, alterations in the morphology of the knobs, and the loss of 
cytoadherence to ICAM-1. This effect appears to be mediated by a Ca2+-
dependent mechanism, as BAPTA-AM was able to rescue KAHRP loss. 
Interestingly, it appears that the cysteine protease μ-calpain is responsible for 
this degradation, as ALLN and E64-d were both able to effectively inhibit 
KAHRP degradation. However, both these inhibitors are not specific to μ-






Figure 6.7 Representative cytoadhesion outcomes. Parasite cultures were placed on 
ice to inhibit growth. CHO cells expressing ICAM-1 were either not preincubated or 
were preincubated with anti-ICAM-1 antibodies. Parasites were then overlaid on the 

























Figure 6.8 DV permeabilization disrupts cytoadherence. Treated parasites were 
overlaid on ICAM-1-expressing CHO cells and allowed to adhere before unattached 
cells were washed off. Cells were then fixed and stained with Giemsa, and 
enumerated under light microscopy. Each run included a uRBC control to ensure 
sufficient washing. *, p < 0.05, Wilcoxon signed-rank test against the ice-treated 
control. 
* * * * * 
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discussed, can degrade cytoskeletal proteins (Ettari et al., 2010). Plasmepsin 
II, although an aspartic protease, is surprisingly also inhibitable by ALLN, a 
calpain inhibitor (Kim et al., 2006). However, the calcium-dependence of 
KAHRP degradation provides more evidence for the hypothesis that KAHRP 
loss is mediated by the Ca2+-activated μ-calpain. 
 
During inflammation, tumor necrosis factor-α (TNFα) triggers the increased 
expression of ICAM-1 by vascular endothelial cells (Burke-Gaffney and 
Hellewell, 1996; Couffinhal et al., 1993). Leukocyte extravasation at the site 
of inflammation involves rolling adhesion followed by chemokine-mediated 
arrest and transendothelial migration (Alon and Ley, 2008; Long, 2011). This 
rolling adhesion is facilitated by ICAM-1, through interactions with the 
lymphocyte function-associated antigen 1 (LFA-1) expressed on the leukocyte 
surface (Sigal et al., 2000; Smith et al., 1989; Yang et al., 2005). Similarly, 
during P. falciparum infection, TNFα and endothelial ICAM-1 levels are 
increased (Kwiatkowski et al., 1990; Turner et al., 1998, 1994). Here, ICAM-1 
aids in the adhesion of pRBCs instead. ICAM-1 enhances rolling adhesion of 
pRBCs, working synergistically with another ligand CD36 to facilitate parasite 
cytoadhesion. Blocking of either ICAM-1 or CD36 with antibodies inhibited 
cytoadhesion by 95% and 50% respectively in an in vitro model designed to 
mimic the shear stresses in blood vessels (Gray et al., 2003). Isolates from 
patients with cerebral malaria demonstrate the highest level of ICAM-1 
binding compared to patients with other manifestations of malaria (Newbold et 
al., 1997). CD36 binding is not associated with cerebral malaria, but this is not 
surprising as CD36 expression in the brain microvessel endothelium is 
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suppressed (Ho et al., 1991a; Turner et al., 1994). This hints at the critical role 
ICAM-1 binding plays in this very fatal form of malaria. This chapter 
demonstrates that ICAM-1 binding is reduced upon treatment with the three 
DV-disrupting compounds, suggesting that DV disruption could be a strategy 






7.1 Imaging flow cytometry screen for DV disruptors 
A high-content system was used in the DV disruptor screen reported here. The 
ImageStream assay made use of the fact that in 3D7, Fluo-4 is sequestered into 
the DV, and disruption of this organelle results in the release of Fluo-4 into the 
surroundings. Validation by confocal microscopy showed that the enlarged 
Fluo-4 fluorescence area was a true redistribution of fluorescence into the 
parasite cytosol; the resolution of the ImageStream system does not allow the 
visualization of the DV membrane and the increased area could simply have 
been due to DV swelling, a known phenotype when hemoglobin digestion is 
blocked (Rosenthal et al., 1988; Sijwali et al., 2006).  
 
However, this redistribution may not be a result of DV disruption. As 
discussed in Chapter 3, this apparent rupture of the DV may be a result of 
PfMDR1 inhibition and competition, or an increase of cytosolic Ca2+ due to 
the release of calcium from another source such as the endoplasmic reticulum. 
Previous work in our laboratory confirmed the CQ-induced breach of the DV 
by electron microscopy and staining for plasmepsin IV, a DV-resident 
hemoglobinase (Ch’ng et al., 2011, 2014). Here, DV breach was validated by 
assessing downstream manifestations associated with this rupture, namely 
DNA degradation and loss of mitochondrial polarization. This is admittedly a 
poor proxy, as an assumption of causation is made here: that DV rupture 
causes this PCD-like phenotype, instead of these features incidentally 
manifesting together. However, in order to scale up the screening 
methodology to large compound libraries of tens of thousands of compounds, 
a rapid validation step is required to select compounds that do induce cell 
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death. Of the two, DNA degradation is probably the more useful marker of 
cell death as discussed in Chapter 4, as the parasite appears able to survive 
ΔΨm loss. This thus allows for a rapid assay to identify true hits. A recent 
report from our laboratory demonstrates the utility of this screen: from a 
library of 4,440 compounds, 254 hits were obtained (Chia et al., 2016). 
Validating such a large number of hits by electron microscopy or 
immunocytochemistry would be unfeasible. 
  
One possibility to bypass this limitation could be to use a line of P. falciparum 
that expresses a fluorescent protein in the DV. In fact, the trafficking of 
plasmepsin II has been tracked by tagging it with green fluorescent protein 
(GFP), showing that it clearly localizes to the DV (Klemba et al., 2004). 
Conceivably, this transgenic P. falciparum strain can be easily adapted to the 
ImageStream assay, immediately providing confirmation that the DV rupture 
involves protein (plasmepsin) egress from the DV. However, optimizing the 
assay for this GFP-labelled parasite would render it less versatile, in that any 
strain that is screened would require a tedious process of transfection, 
selection, and validation prior to use. Another limitation of this assay is the 
fact that the DV localization of Fluo-4 depends on the genetic background of 
the parasite strain (Rohrbach et al., 2006). Although this may render some 
strains unusable for this screen, it is simple to validate any strain or clinical 
isolate by confocal microscopy prior to the screen. Downstream assessment of 
DV rupture could then instead be performed with fluorescence microscopy, 
perhaps staining for plasmepsin II or FP-2 using antibodies against a well-
conserved epitope. Needless to say, screening large libraries directly with 
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immunocytochemistry on the imaging flow cytometer would be cost-
prohibitive for most academic laboratories, and this should therefore be 
reserved as a validation step. 
 
The 3D7 strain was chosen for this screen because it is a well-established 
model strain with a fully sequenced genome (Gardner et al., 2002). However, 
the limitations of using this strain can easily be seen when the hits were tested 
on 7G8 and K1 (Chapters 3 and 4). Disappointingly, the CQ-resistant parasites 
appeared to be cross-resistant to QC and DCB. Although performing the 
screen on 7G8 and K1 may seem valuable, this author believes that because of 
the emergence of artemisinin-resistant parasites, more value might be obtained 
by screening libraries against an artemisinin-resistant isolate. It may prove 
fruitful to develop a laboratory strain from such an isolate, and one that 
sequesters Fluo-4 into the DV. However, much work has to be done to 
demonstrate that the characteristics of a clinical isolate, particularly in respect 
to artemisinin resistance, can be maintained in the laboratory. Furthermore, 
generating a complete genome from a new P. falciparum strain is no small 
feat, given the high (~80%) A-T content of the parasite genome (Gardner et 
al., 2002). With the published 3D7 genome as a backbone sequence, however, 
it should be comparatively easier. 
 
7.2 PCD in P. falciparum 
Previous reports have linked mitochondrial depolarization and DNA 
degradation to DV rupture (Ch’ng et al., 2011, 2014). However, there is little 
evidence to support the hypothesis that the permeabilization of the DV causes 
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these features, and that these features are indicative of cell death. In Chapter 4, 
it was shown that CQ-induced mitochondrial depolarization is not a 
characteristic of parasite death. Given that CQ has been reported to interact 
with DNA (Meshnick, 1990; O’Brien et al., 1966), DNA degradation too may 
not be causally linked to DV disruption. Furthermore, DV rupture does not 
lead to increased phosphatidylserine presentation or phagocytosis, both key 
features of mammalian apoptosis (Chapter 5). The differences between CQ-
induced cell death and apoptosis are, one might think, more than any 
similarities. Moreover, it has not been demonstrated that the release of DV 
contents is utilized by the parasite in its natural life cycle to induce cell death. 
It is the opinion of this author that there is still insufficient evidence to 
conclude that a PCD pathway exists in P. falciparum. 
 
In order to show that DV disruption truly induces cell death, there is a need to 
inhibit DV rupture in the presence of high CQ concentrations. However, the 
mechanism by which the three DV disruptors, CQ, QC, and DCB breach the 
DV is unknown. One possibility is through oxidative damage induced by free 
heme. As CQ and QC are both quinoline antimalarials and prevent the 
incorporation of heme into hemozoin, this is a reasonable hypothesis. DCB, 
however, has not been reported to inhibit hemozoin formation. Interestingly, 
CQ can interact with free heme to enhance peroxidation of phospholipid 
membranes, possibly explaining how CQ can cause DV lysis; this is 
inhibitable by tocopherol, a type of vitamin E (Sugioka et al., 1987). If this is 
indeed the mechanism by which CQ ruptures the DV, tocopherol may serve to 
uncouple the effect of DV disruption from other incidental features of CQ 
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treatment. This could provide more evidence that DV rupture is responsible 
for DNA degradation or some extent of mitochondrial depolarization. 
However, it is necessary to control for the antioxidant effect of tocopherol 
with another antioxidant that does not inhibit DV rupture, perhaps one that is 
excluded from the DV. Whether such a control is available remains to be seen. 
Also, since serum levels of CQ in a clinical dose exceeds that required to 
induce DV disruption in 3D7, and since accumulation of CQ in the DV cannot 
fully account for resistance against CQ’s cytocidal effects (Cabrera et al., 
2009; Lehane et al., 2011), the CQ-resistant parasite probably has another 
mechanism of resistance. Perhaps increased antioxidant capabilities may be 
contributing to CQ resistance. 
 
7.3 KAHRP degradation through DV disruption 
Perhaps the most exciting finding reported in this thesis is the loss of KAHRP 
following DV lysis. The majority of reports targeting cytoadhesion attempt to 
inhibit parasite interaction with the endothelial lining, such as by mimicking 
the binding partners of the parasite proteins (Adams et al., 2005; Baruch et al., 
1999; Crandall et al., 1993; Leitgeb et al., 2011; Patil et al., 2011). However, 
the parasite genome contains multiple copies of genes coding for 
cytoadherence factors. In 3D7, there exists 59 copies of var genes (coding for 
PfEMP1), 149 rif and 28 stevor genes (rif and stevor encode less-characterized 
surface antigens) (Gardner et al., 2002). Attempting to develop compounds 
that can inhibit the product of all 59 var genes, and their various alleles, 
appears to be an exercise in futility. A previous report has also shown that 
several antimalarial drugs currently used do not result in the rapid loss of 
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cytoadherence (except artesunate), detecting a decrease only 24 h after 
treatment (Hughes et al., 2010). Here, a novel strategy to target cytoadhesion 
may prove fruitful. KAHRP is expressed by a single gene (Rug et al., 2006) 
and presents a more viable target. Given that KAHRP loss can be ablated by 
the Ca2+ chelator BAPTA-AM and calpain inhibitors E64-d and ALLN, the 
degradation of KAHRP seems to be mediated by μ-calpain, in effect hijacking 
the host PCD pathway to destroy the parasite protein. This provides the 
advantage of not relying on a parasite target, as the parasite may evolve 
resistance. A model of how DV disruption effects KAHRP degradation is 
shown in Figure 7.1. Another implication of this finding is that an assay for 
the rapid identification of cytoadhesion-disrupting drugs is now possible, 
simply by screening for DV rupture. 
 
One interesting point to note is that KAHRP signal is lost instead of 
redistributed; this implies that the epitope of the antibody against KAHRP has 
been degraded. The μ-calpain cleavage site is not well-characterized and 
appears not to be specific to a particular sequence (Cuerrier et al., 2005; 
Sorimachi et al., 2012; Tompa et al., 2004). Identification of the KAHRP 
epitope might provide a clue to the cleavage sites of μ-calpain, and genetic 
analyses can assess if this site is conserved. Multiple cleavage sites would 








Figure 7.1 Proposed model of DV-mediated loss of cytoadherence. In the 
untreated parasite, Ca2+ stores include the DV, the endoplasmic reticulum, and the 
parasitophorous vacuole. Upon DV disruption, Ca2+ and proteases such as falcipains 
are released from the acidic DV into the neutral parasite cytosol. Further collapse of 
the membrane integrity of the dying parasite may be caused by these released 
proteases; Ca2+ levels in the cytosol of the host cell become elevated as other Ca2+ 
stores are disrupted. In the host erythrocyte, proteases such as μ-calpain may be 
activated in a similar manner to eryptosis. Combined with the parasite-released 
proteases, this could then lead to the degradation of KAHRP, ankyrin, and spectrin. 
The disruption of the knob complex results in the loss of cytoadherence. 
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7.4 Further work 
Although all the DV disruptors initiated KAHRP degradation and loss of 
cytoadherence, a sample size of three compounds is too small to provide 
confidence that this phenomenon is generalizable to all DV-disrupting drugs. 
To show that targeting the DV is a viable strategy to disrupt parasite 
cytoadhesion, more compounds need to be tested. The ImageStream assay 
should be employed to identify more compounds that rupture the DV, and 
these compounds assessed for induction of KAHRP degradation. 
 
The exact mechanism through which KAHRP is degraded should also be 
elucidated. Although ALLN and E64-d are known inhibitors of μ-calpain, they 
are both broad-acting and may inhibit other proteases. For example, 
erythrocytes contain functional proteasomes (Neelam et al., 2011), and these 
may contribute to KAHRP loss. Also, given that plasmepsin II and FP-2 are 
known to degrade cytoskeletal proteins, these should also be ruled out as 
possible mediators of KAHRP loss. FP-2 and plasmepsin II are not critical for 
parasite growth and survival (Liu et al., 2005; Sijwali et al., 2004, 2006), and a 
knockout mutant may be used to investigate their roles, if any, in this 
phenomenon. To examine the role of μ-calpain, erythrocytes that have been 
depleted of μ-calpain (O’Neill et al., 2003) may be used to this effect. 
Knockouts of μ-calpain prior to differentiation may be feasible but it remains 
to be established that calpain knockouts do not adversely affect differentiation. 
Another candidate may be the single calpain expressed by P. falciparum (Pf-
calpain). This protein is found in the cytoplasm and nucleus of the parasite and 
could possibly be activated by the release of Ca2+ (Choi et al., 2010; Farias et 
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al., 2005). However, this calpain is essential to the parasite (Russo et al., 
2009), and knockdown mutants may be too compromised to draw strong 
conclusions. 
 
Further work is also required to validate KAHRP loss. Here, 
immunofluorescence was used to assess this; this was a fortuitous finding as 
redistribution of KAHRP was expected instead. A more convincing 
experiment to demonstrate KAHRP loss would be to perform Western blots 
for KAHRP. The use of purified KAHRP and μ-calpain to demonstrate 
proteolysis of KAHRP should also be done, in order to support the postulate 
that μ-calpain is responsible for the degradation. In the same way, FP-2 and 
plasmepsin II may be investigated for KAHRP degradation. 
  
One aspect of the model presented in Figure 7.1 is that the parasitophorous 
vacuole membrane ruptures eventually, allowing the release of Ca2+ and 
proteases into the RBC cytosol. However, this may not be necessary if 
extracellular Ca2+ is no longer being sequestered by the parasite and μ-calpain 
activation by the influx of extracellular Ca2+ is responsible for the observed 
phenotype. To determine if this is the case, Ca2+ concentration in the RBC 
cytosol can be determined in the absence of extracellular Ca2+, for example, by 
a ratiometric Ca2+ indicator such as Fura Red. This fluorescent dye allows for 
the quantification of Ca2+ concentration by comparing the emission intensities 
at two wavelengths (Kurebayashi et al., 1993; Wendt et al., 2015). This should 
be coupled with immunocytochemistry to detect a parasite protein that is 
localized to the parasite cytoplasm, or the parasite DV such as FP-2.  
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Here, only the ligand ICAM-1 was investigated for cytoadhesion. P. 
falciparum also adheres through interactions with many other binding 
partners, such as CD36, chondroitin sulfate A, thrombospondin and VCAM-1. 
CD36 is a major binding partner of PfEMP1 and the potential to disrupt this 
interaction is worth investigating. Besides binding to the endothelial wall, 
pRBCs also form rosettes by recruiting neighbouring uRBCs; the formation of 
rosettes is correlated with pathology (Ho et al., 1991b). Whether DV 
disruption can similarly interfere with rosetting remains to be elucidated. 
Rosetting is mediated by PfEMP1 in blood group O RBCs but involve RIFINs 
when rosetting with blood group A RBCs (Goel et al., 2015). Another parasite 
protein, STEVOR, aids in rosetting by interacting with glycophorin C on 
neighbouring RBCs (Niang et al., 2014). If DV lysis can disrupt both 
cytoadhesion and rosetting, it may prove exceptionally useful in our fight 
against malaria. 
 
Although it was demonstrated that DV disruption can inhibit cytoadhesion, 
one aspect that was not examined is whether DV disruption can reverse it — in 
other words, whether DV disruption can detach parasites that have already 
attached. Patients with severe malaria can have substantial numbers of 
parasites that are already sequestered in the small vessels, and killing these 
parasites without causing them to return to the peripheral circulation may not 
resolve the disease in the expeditious manner that is desired. In fact, it could 
possibly worsen the clinical outcome as dead parasites do not egress and 
reinvade to form less-adherent rings, thus leaving behind “corpses” that 
continue to occlude these vessels (Hughes et al., 2010). 
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Although there is little evidence that P. falciparum encodes a cell death 
pathway, most work on PCD in this parasite focuses on parasite-expressed 
factors. One possibility could be that the parasite uses host cell death factors in 
its own death. Interestingly, TNFα exposure has been shown to cause Ca2+ 
dysfunction of the endoplasmic reticulum in isolated parasites as well as 
inhibit parasite reinvasion, but do not result in crisis forms of the parasite 
(Clark et al., 1990; Cruz et al., 2016; Jensen et al., 1987). Whether this is a 
true cytocidal effect has yet to be established. If so, this could constitute a 
mechanism by which the parasite commits suicide to restrict parasitemia, as 
TNFα levels rise with parasite burden. Activation of the host cell death 
machinery such as μ-calpain may be involved, and given that the parasite 
inevitably resides in the host cell during this stage of its life cycle, this can 
reasonably be defined as parasite PCD. 
 
7.5 Conclusion 
This thesis describes the establishment of a high-content assay for the 
screening of DV disruptors. Through this assay, two novel compounds that 
disrupt the DV: QC and DCB. Furthermore, the application of this assay 
allowed for the correlation of DV disruption to the cytocidal effects of CQ, as 
well as two previously-described PCD-like manifestations of CQ treatment. 
However, these PCD-like features may not be truly due to a PCD pathway in 
the parasite; in particular, mitochondrial depolarization is almost certainly not 
an indicator of parasite cell death. Furthermore, DV disruption did not induce 
phagocytosis of the parasites. These difference with apoptosis and other 
mammalian PCD pathways suggest that the parasite does not commit suicide 
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in any way similar to mammalian cells. However, the parasite may co-opt a 
host suicide pathway for an essential step of its life cycle, in that it activates μ-
calpain to aid in its egress from the host (Chandramohanadas et al., 2009). 
Here, it appears that DV disruption turns this against the parasite itself, by 
forcing the parasite to prematurely activate μ-calpain and destroy its ability to 
sequester itself from splenic clearance. Further validation of this proposed 
pathway should be performed, however, to determine if DV disruption indeed 
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Figure S3.1 Stage of parasites for DV-disruption screen. Parasites at the beginning 
of drug incubation were at approximately 32 h post-invasion. The window of 
















Figure S3.2 Gating strategy for single round cells. Cells were gated by area and 
aspect ratio prior to analysis. Boundary for the gate were determined by visually 


















Figure S3.3 Gating for the sub-G1 population. Gate R2 represents the entire 
Hoechst-positive population, indicative of the parasitemia. Gate R3 is selected to 






















Figure S5.1 Supernatant of treated cells impart DHE staining. Treated pRBCs or 
uRBCs were stained with DHE and incubated in TCM for 4 h. Cells were then 
pelleted and the supernatant used to resuspend THP-1 cells. THP-1 cells were then 
incubated in the supernant for 4 h. Similar lysis steps were performed even in the 
absence of RBCs. “THP1 alone” are THP-1 cells that have not been incubated in 

































   
 
Figure S6.1 Representative histogram and images for circularity. 
(A) The Circularity function was applied to the bright field images to determine the 
sphericity of the cells. Circularity is measured as the average distance of the centre of 
an object to its boundary divided by the variation in this distance; the higher the 
variation, the lower the Circularity score. Note that the software cannot distinguish 
between cells that are truly spherical or are simply facing the imaging plane. (B) 
Representative images of cells within the region R7. (C) Representative images of 









Figure S6.2 E64-d and ALLN inhibition of morphological changes. Parasites were 
pretreated with (A) the broad cysteine protease inhibitor E64-d or (B) the μ-calpain 
inhibitor ALLN prior to incubation with the test compounds. No-pretreatment data 
from Figure 6.2 are presented here for comparison. *, p < 0.05; **, p < 0.01; 



























































































Figure S6.3 Z-VAD and AEBSF inhibition of morphological changes. Parasites 
were pretreated with (A) the membrane-permeable pancaspase inhibitor z-
VAD(Ome)-fmk or (B) the serine protease inhibitor AEBSF prior to incubation with 
the test compounds. No-pretreatment data from Figure 6.2 are presented here for 
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